,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,BioPlanet_2019,T cell receptor regulation of apoptosis,13 of 603,1.8288750082106227e-11,8.449402537933076e-09,0,0,18.56020633750921,458.8961831424026,TOP2A;EGR1;JUN;CDKN1A;FOS;YBX1;SOD2;CLU;CCND1;PTMA;ATF4;PTGES;HMGN1
1,BioPlanet_2019,TGF-beta signaling pathway,8 of 185,1.1165641081343231e-09,2.579263089790287e-07,0,0,31.940274414850688,658.3851840169425,KLF10;ITGB1;JUN;CCND1;CDK1;FOS;RNF111;SMAD7
2,BioPlanet_2019,AP-1 transcription factor network,6 of 70,2.6473186616465193e-09,4.0768707389356406e-07,0,0,62.1875,1228.1856213942756,EGR1;ACTA1;JUN;CCND1;CDK1;FOS
3,BioPlanet_2019,Regular glucocorticoid receptor pathway,6 of 82,6.9616533065822385e-09,8.040709569102484e-07,0,0,52.33684210526316,983.034994379904,EGR1;JUN;CDKN1A;SUMO2;FOS;CDK5R1
4,BioPlanet_2019,BDNF signaling pathway,7 of 261,3.593307218644853e-07,3.320215870027845e-05,0,0,18.73065435786044,277.944604110345,KLF10;EGR1;JUN;BTG2;CDKN1A;FOS;CLU
5,BioPlanet_2019,Signaling of hepatocyte growth factor receptor,4 of 38,6.245439764887541e-07,4.808988618963407e-05,0,0,73.2720588235294,1046.7825174135353,ITGB1;ACTA1;JUN;FOS
6,BioPlanet_2019,Gastrin pathway,4 of 44,1.139798755921553e-06,7.215280907545816e-05,0,0,62.2625,852.0410710899093,ITGB1;JUN;CCND1;FOS
7,BioPlanet_2019,RhoA signaling pathway,4 of 45,1.249399291349925e-06,7.215280907545816e-05,0,0,60.74085365853659,825.64117228515,ITGB1;ACTA1;JUN;FOS
8,BioPlanet_2019,ATF2 transcription factor network,4 of 59,3.748715752488803e-06,0.0001914822315438504,0,0,45.24772727272728,565.3295045539002,ACHE;JUN;CCND1;FOS
9,BioPlanet_2019,Mitotic G1-G1/S phases,5 of 135,4.144637046403688e-06,0.0001914822315438504,0,0,24.60794044665012,304.98331677685945,TOP2A;CDKN1A;CCND1;CDK1;MNAT1
10,BioPlanet_2019,Signaling events mediated by focal adhesion kinase,4 of 62,4.577174654039502e-06,0.00019224133546965908,0,0,42.90086206896552,527.4415872136912,ITGB1;ACTA1;JUN;CCND1
11,BioPlanet_2019,Validated nuclear estrogen receptor alpha network,4 of 64,5.20000141380238e-06,0.0002002000544313916,0,0,41.46666666666667,504.5187821883957,JUN;MTA1;CCND1;HSF2
12,BioPlanet_2019,G1 to S cell cycle control,4 of 67,6.248942970591274e-06,0.0002220778194163976,0,0,39.48611111111112,473.1659482924641,CDKN1A;CCND1;CDK1;MNAT1
13,BioPlanet_2019,Myc repressed pathway,4 of 73,8.805873341129527e-06,0.0002671679792479249,0,0,36.04166666666666,419.5283026413933,ITGB1;CDKN1A;CCND1;CLU
14,BioPlanet_2019,Signaling events mediated by PRL,3 of 23,9.252570709884843e-06,0.0002671679792479249,0,0,90.65454545454546,1050.7414022639623,ITGB1;EGR1;CDKN1A
15,BioPlanet_2019,Cyclins and cell cycle regulation,3 of 23,9.252570709884843e-06,0.0002671679792479249,0,0,90.65454545454546,1050.7414022639623,CDKN1A;CCND1;CDK1
16,BioPlanet_2019,ATM-dependent DNA damage response,4 of 82,1.3988659786163267e-05,0.0003590422678448572,0,0,31.868589743589745,356.20362722766305,JUN;CDKN1A;CCND1;SOD2
17,BioPlanet_2019,SMAD2/3 nuclear pathway,4 of 82,1.3988659786163267e-05,0.0003590422678448572,0,0,31.868589743589745,356.20362722766305,JUN;CDKN1A;FOS;SMAD7
18,BioPlanet_2019,Oxidative stress,3 of 27,1.520626668798976e-05,0.00036975237946585625,0,0,75.53030303030303,837.9182972858675,GCLC;FOS;SOD2
19,BioPlanet_2019,Cell cycle: G1/S checkpoint,3 of 28,1.700998120085429e-05,0.0003886558680199611,0,0,72.50545454545454,796.2338938513493,CDKN1A;CCND1;CDK1
20,BioPlanet_2019,Oncostatin M,6 of 311,1.7712189047550413e-05,0.0003886558680199611,0,0,12.891147540983606,141.04536482775492,KLF10;JUN;CDKN1A;CCND1;SOD2;CDK5R1
21,BioPlanet_2019,"Androgen receptor signaling, proteolysis, and transcription regulation",4 of 88,1.850742228666481e-05,0.0003886558680199611,0,0,29.58333333333333,322.3796032573378,JUN;CDKN1A;CCND1;FOS
22,BioPlanet_2019,MAPK/TRK pathway,3 of 34,3.084116878007714e-05,0.0006195052163650277,0,0,58.45454545454545,607.1474956261615,EGR1;FOS;CDK5R1
23,BioPlanet_2019,FRA pathway,3 of 37,3.989789745274057e-05,0.000768034525965256,0,0,53.288770053475936,539.7719131881752,JUN;CCND1;ATF4
24,BioPlanet_2019,Cyclin D-associated events in G1,3 of 38,4.3264215430399456e-05,0.000799522701153782,0,0,51.763636363636365,520.1305788280517,CDKN1A;CCND1;MNAT1
25,BioPlanet_2019,FOXM1 transcription factor network,3 of 41,5.446773949824636e-05,0.0009678498326226852,0,0,47.66985645933014,468.0179775163143,CCND1;CDK1;FOS
26,BioPlanet_2019,TGF-beta regulation of extracellular matrix,7 of 565,5.664571269820571e-05,0.0009692710839470756,0,0,8.39463601532567,82.08857896648016,KLF10;ACTA1;MTA1;CCND1;STMN1;SMAD7;CDK5R1
27,BioPlanet_2019,Interleukin-1 regulation of extracellular matrix,4 of 120,6.258164596443844e-05,0.0010325971584132,0,0,21.38793103448276,207.0146083096024,JUN;FOS;SOD2;PTGES
28,BioPlanet_2019,Wnt interactions in lipid metabolism and immune response,3 of 45,7.214694059722266e-05,0.0011493753984798,0,0,43.121212121212125,411.2386205570567,KLF10;CCND1;FOS
29,BioPlanet_2019,Agrin in postsynaptic differentiation,3 of 47,8.223927228069132e-05,0.0011905138614268,0,0,41.15702479338843,387.1179377935321,ITGB1;ACTA1;JUN
30,BioPlanet_2019,Regulation of NFAT transcription factors,3 of 47,8.223927228069132e-05,0.0011905138614268,0,0,41.15702479338843,387.1179377935321,EGR1;JUN;FOS
31,BioPlanet_2019,Support of platelet aggregation by Eph kinases and ephrins,2 of 8,8.760274454585359e-05,0.0011905138614268,0,0,195.66666666666663,1828.0546203524368,ITGB1;ACTA1
32,BioPlanet_2019,TSP1-induced apoptosis in microvascular endothelial cell,2 of 8,8.760274454585359e-05,0.0011905138614268,0,0,195.66666666666663,1828.0546203524368,JUN;FOS
33,BioPlanet_2019,Presenilin action in Notch and Wnt signaling,3 of 48,8.761357421756333e-05,0.0011905138614268,0,0,40.24040404040404,375.9489772934714,JUN;CCND1;FOS
34,BioPlanet_2019,Interleukin-2 signaling pathway,8 of 847,0.00010533265642205446,0.0013903910647711,0,0,6.512855440149838,59.64725098306531,APP;JUN;CCND1;CDK1;FOS;MNAT1;ATF4;EZH2
35,BioPlanet_2019,p53 signaling pathway,4 of 139,0.0001107268477732558,0.0014209945464234,0,0,18.360185185185184,167.2327226344515,JUN;BTG2;CDKN1A;ARID3A
36,BioPlanet_2019,Interleukin-5 regulation of apoptosis,4 of 144,0.000126919781385289,0.0015847821351352,0,0,17.7,158.80360905269274,EGR1;FOS;SOD2;ATF4
37,BioPlanet_2019,Activation of the AP-1 family of transcription factors,2 of 10,0.00014047193487328206,0.0016640521515758,0,0,146.73529411764707,1301.6158433360367,JUN;FOS
38,BioPlanet_2019,Deregulation of CDK5 in Alzheimer's disease,2 of 10,0.00014047193487328206,0.0016640521515758,0,0,146.73529411764707,1301.6158433360367,APP;CDK5R1
39,BioPlanet_2019,Myometrial relaxation and contraction pathways,4 of 155,0.00016850146316605766,0.0018006845434871,0,0,16.401490066225165,142.5054309845237,ACTA1;JUN;FOS;ATF4
40,BioPlanet_2019,BTG family proteins and cell cycle regulation,2 of 11,0.0001714937660463913,0.0018006845434871,0,0,130.4248366013072,1130.9090161319034,BTG2;CCND1
41,BioPlanet_2019,Sonic Hedgehog (SHH) receptor PTCH1 regulation of cell cycle,2 of 11,0.0001714937660463913,0.0018006845434871,0,0,130.4248366013072,1130.9090161319034,CDK1;MNAT1
42,BioPlanet_2019,Erythropoietin-mediated neuroprotection through NF-kB,2 of 11,0.0001714937660463913,0.0018006845434871,0,0,130.4248366013072,1130.9090161319034,CDKN1A;SOD2
43,BioPlanet_2019,p38 gamma/delta MAPK pathway,2 of 11,0.0001714937660463913,0.0018006845434871,0,0,130.4248366013072,1130.9090161319034,CCND1;STMN1
44,BioPlanet_2019,Toll receptor cascades,4 of 159,0.0001858121753265661,0.0018911288524767,0,0,15.975,137.23761791728668,APP;JUN;CDK1;FOS
45,BioPlanet_2019,Colorectal cancer,3 of 62,0.0001882942147487652,0.0018911288524767,0,0,30.67026194144838,263.07432044187647,JUN;CCND1;FOS
46,BioPlanet_2019,Retinoblastoma protein regulation,3 of 66,0.00022670253906009047,0.0022284377243779,0,0,28.71717171717172,240.99082352129253,JUN;CDKN1A;CCND1
47,BioPlanet_2019,MAPK signaling pathway,5 of 314,0.00023362733273182905,0.0022349143777947,0,0,10.259421651529388,85.78706070828444,JUN;STMN1;FOS;ATF4;HMGN1
48,BioPlanet_2019,Telomerase regulation,3 of 67,0.00023703637340247093,0.0022349143777947,0,0,28.267045454545453,235.95342243072216,JUN;CCND1;FOS
49,BioPlanet_2019,MAP kinase downregulation by phosphorylation of MEK1 by Cdk5/p35,2 of 13,0.0002426595424912267,0.0022421741726189,0,0,106.70053475935828,888.1593696806578,EGR1;CDK5R1
50,BioPlanet_2019,CD8/T cell receptor downstream pathway,3 of 68,0.0002476705405233624,0.0022436037200351,0,0,27.83076923076923,231.0903198395103,EGR1;JUN;FOS
51,BioPlanet_2019,MicroRNA regulation of DNA damage response,3 of 70,0.0002698549643706707,0.0023875274635093,0,0,26.99728629579376,221.85359942583648,CDKN1A;CCND1;CDK1
52,BioPlanet_2019,Pathways in cancer,5 of 325,0.0002738938432164355,0.0023875274635093,0,0,9.901209677419354,81.21734531122668,ITGB1;JUN;CDKN1A;CCND1;FOS
53,BioPlanet_2019,Cyclin A-Cdk2-associated events at S phase entry,3 of 72,0.0002932857800566364,0.0024636005524757,0,0,26.21212121212121,213.21891066271564,CDKN1A;CCND1;MNAT1
54,BioPlanet_2019,Leishmaniasis,3 of 72,0.0002932857800566364,0.0024636005524757,0,0,26.21212121212121,213.21891066271564,ITGB1;JUN;FOS
55,BioPlanet_2019,RANKL regulation of apoptosis and immune response,3 of 74,0.0003179926173270372,0.0024652447509394,0,0,25.471190781049938,205.1317864433363,EGR1;JUN;CDK1
56,BioPlanet_2019,Immune system,8 of 998,0.0003243115220753925,0.0024652447509394,0,0,5.475901875901876,43.99233343484177,ITGB1;EGR1;APP;JUN;CDKN1A;CDK1;FOS;RNF111
57,BioPlanet_2019,Repression of pain sensation by the transcriptional regulator DREAM,2 of 15,0.0003259186256199044,0.0024652447509394,0,0,90.27601809954751,724.8137654755144,JUN;FOS
58,BioPlanet_2019,Calcium signaling by HBx of hepatitis B virus,2 of 15,0.0003259186256199044,0.0024652447509394,0,0,90.27601809954751,724.8137654755144,JUN;FOS
59,BioPlanet_2019,Cyclin A/B1-associated events during G2/M transition,2 of 15,0.0003259186256199044,0.0024652447509394,0,0,90.27601809954751,724.8137654755144,CDK1;MNAT1
60,BioPlanet_2019,Mu-calpain pathway,2 of 15,0.0003259186256199044,0.0024652447509394,0,0,90.27601809954751,724.8137654755144,ITGB1;ACTA1
61,BioPlanet_2019,Prolactin activation of MAPK signaling,3 of 75,0.0003308337111650393,0.0024652447509394,0,0,25.116161616161616,201.278274259451,ITGB1;JUN;FOS
62,BioPlanet_2019,Rb tumor suppressor/checkpoint signaling in response to DNA damage,2 of 16,0.0003720571862084629,0.0026444680004355,0,0,83.82352941176471,661.9093976190027,CDKN1A;CDK1
63,BioPlanet_2019,B cell survival pathway,2 of 16,0.0003720571862084629,0.0026444680004355,0,0,83.82352941176471,661.9093976190027,ITGB1;FOS
64,BioPlanet_2019,Selenium metabolism and selenoproteins,2 of 16,0.0003720571862084629,0.0026444680004355,0,0,83.82352941176471,661.9093976190027,JUN;FOS
65,BioPlanet_2019,Cadmium-induced DNA biosynthesis and proliferation in macrophages,2 of 17,0.0004211879595115378,0.0029483157165807,0,0,78.23137254901961,608.0479736697338,JUN;FOS
66,BioPlanet_2019,Differentiation pathway in PC12 cells,3 of 84,0.00046168069209550543,0.003169056375606,0,0,22.31537598204265,171.39630351848535,EGR1;JUN;FOS
67,BioPlanet_2019,Pertussis toxin-insensitive CCR5 signaling in macrophage,2 of 18,0.00047330062752558495,0.003169056375606,0,0,73.33823529411765,561.461379980425,JUN;FOS
68,BioPlanet_2019,Effect of METS on macrophage differentiation,2 of 18,0.00047330062752558495,0.003169056375606,0,0,73.33823529411765,561.461379980425,JUN;FOS
69,BioPlanet_2019,Prostate cancer,3 of 89,0.0005468692669122734,0.003609337161621,0,0,21.01268498942917,157.83259724067076,CDKN1A;CCND1;ATF4
70,BioPlanet_2019,Dual incision reaction in GG-NER,2 of 20,0.000586430503116779,0.0036612282762155,0,0,65.18300653594771,485.05650058138406,XPC;MNAT1
71,BioPlanet_2019,Estrogen receptor signaling pathway,2 of 20,0.000586430503116779,0.0036612282762155,0,0,65.18300653594771,485.05650058138406,JUN;FOS
72,BioPlanet_2019,ID regulation of gene expression,2 of 20,0.000586430503116779,0.0036612282762155,0,0,65.18300653594771,485.05650058138406,CDKN1A;CCND1
73,BioPlanet_2019,Nerve growth factor (NGF) pathway,2 of 20,0.000586430503116779,0.0036612282762155,0,0,65.18300653594771,485.05650058138406,JUN;FOS
74,BioPlanet_2019,ERBB signaling pathway,3 of 94,0.0006415225024258714,0.003884563212852,0,0,19.853146853146853,145.95371060365636,JUN;CDKN1A;CCND1
75,BioPlanet_2019,IGF1 signaling pathway,2 of 21,0.0006474272021420127,0.003884563212852,0,0,61.749226006191954,453.3939512870567,JUN;FOS
76,BioPlanet_2019,Oxidative stress-induced gene expression via Nrf2,2 of 21,0.0006474272021420127,0.003884563212852,0,0,61.749226006191954,453.3939512870567,JUN;FOS
77,BioPlanet_2019,TSH regulation of gene expression,3 of 97,0.0007030288119836389,0.0041640937325184,0,0,19.216634429400383,139.51493133900632,EGR1;JUN;FOS
78,BioPlanet_2019,Progesterone-initiated oocyte maturation,2 of 23,0.0007782330418291474,0.0044942958165633,0,0,55.86274509803921,399.8925970911249,ACTA1;CDK1
79,BioPlanet_2019,Interleukin-11 pathway,2 of 23,0.0007782330418291474,0.0044942958165633,0,0,55.86274509803921,399.8925970911249,JUN;FOS
80,BioPlanet_2019,Inhibition of cellular proliferation by Gleevec,2 of 24,0.0008480218264323183,0.0048368652322435,0,0,53.32085561497326,377.1173065055224,JUN;FOS
81,BioPlanet_2019,ERBB1 downstream pathway,3 of 106,0.0009097376837352594,0.0050639654556029,0,0,17.529567519858784,122.74824179232586,EGR1;JUN;FOS
82,BioPlanet_2019,TPO signaling pathway,2 of 25,0.0009207209919278048,0.0050639654556029,0,0,51.0,356.5080289062332,JUN;FOS
83,BioPlanet_2019,G0 and early G1 pathway,2 of 25,0.0009207209919278048,0.0050639654556029,0,0,51.0,356.5080289062332,TOP2A;CDK1
84,BioPlanet_2019,Physiological and pathological hypertrophy  of the heart,2 of 26,0.0009963204237941185,0.0053523259975916,0,0,48.872549019607845,337.7797704194284,JUN;FOS
85,BioPlanet_2019,Fibroblast growth factor 1,2 of 26,0.0009963204237941185,0.0053523259975916,0,0,48.872549019607845,337.7797704194284,CDKN1A;CCND1
86,BioPlanet_2019,S phase,3 of 112,0.0010668659620447,0.0055793509534417,0,0,16.559633027522935,113.31806453452602,CDKN1A;CCND1;MNAT1
87,BioPlanet_2019,Cell cycle: G2/M checkpoint,2 of 27,0.0010748100321565,0.0055793509534417,0,0,46.91529411764706,320.6947168320981,CDKN1A;CDK1
88,BioPlanet_2019,Mammalian calpain regulation of cell motility,2 of 27,0.0010748100321565,0.0055793509534417,0,0,46.91529411764706,320.6947168320981,ITGB1;ACTA1
89,BioPlanet_2019,Cell cycle,5 of 453,0.0012317343945576,0.0060965301015265,0,0,7.026209677419355,47.070911512950886,TOP2A;CDKN1A;CCND1;CDK1;MNAT1
90,BioPlanet_2019,p53 activity regulation,3 of 118,0.0012401990399985,0.0060965301015265,0,0,15.690909090909091,105.01114856091596,CDKN1A;CCND1;CDK1
91,BioPlanet_2019,Reelin signaling pathway,2 of 29,0.0012404195444664,0.0060965301015265,0,0,43.43572984749456,290.6851787186678,ITGB1;CDK5R1
92,BioPlanet_2019,T cell receptor calcium pathway,2 of 29,0.0012404195444664,0.0060965301015265,0,0,43.43572984749456,290.6851787186678,JUN;FOS
93,BioPlanet_2019,Influence of Ras and Rho proteins on G1 to S transition,2 of 29,0.0012404195444664,0.0060965301015265,0,0,43.43572984749456,290.6851787186678,CDKN1A;CCND1
94,BioPlanet_2019,Interleukin-4 regulation of apoptosis,4 of 267,0.0013071796248939,0.0061950905078535,0,0,9.363593155893536,62.17316695504083,TOP2A;JUN;CDKN1A;FOS
95,BioPlanet_2019,Retinoic acid receptor-mediated signaling,2 of 30,0.00132751939454,0.0061950905078535,0,0,41.88235294117647,277.4472679372888,CDK1;MNAT1
96,BioPlanet_2019,Signaling pathway from G-protein families,2 of 30,0.00132751939454,0.0061950905078535,0,0,41.88235294117647,277.4472679372888,JUN;FOS
97,BioPlanet_2019,Nuclear events mediated by MAP kinases,2 of 30,0.00132751939454,0.0061950905078535,0,0,41.88235294117647,277.4472679372888,JUN;FOS
98,BioPlanet_2019,PDGFA signaling pathway,2 of 30,0.00132751939454,0.0061950905078535,0,0,41.88235294117647,277.4472679372888,JUN;FOS
99,BioPlanet_2019,Alpha-V beta-3 integrin/OPN pathway,2 of 31,0.0014174693130427,0.0064838695309481,0,0,40.43610547667343,265.2156512854863,JUN;FOS
100,BioPlanet_2019,Stathmin and breast cancer resistance to antimicrotubule agents,2 of 31,0.0014174693130427,0.0064838695309481,0,0,40.43610547667343,265.2156512854863,STMN1;CDK1
101,BioPlanet_2019,Global genomic nucleotide excision repair (GG-NER),2 of 33,0.0016058795210156,0.0072736895951885,0,0,37.8235294117647,243.35975347159868,XPC;MNAT1
102,BioPlanet_2019,EGF receptor transactivation by GPCRs in cardiac hypertrophy,2 of 34,0.0017043199561329,0.007571113651283,0,0,36.63970588235294,233.5630697638135,JUN;FOS
103,BioPlanet_2019,EPO receptor signaling,2 of 34,0.0017043199561329,0.007571113651283,0,0,36.63970588235294,233.5630697638135,JUN;FOS
104,BioPlanet_2019,PI3K/PLC/TRK pathway,2 of 36,0.0019096220383147,0.0084023369685849,0,0,34.48096885813149,215.8801718825925,EGR1;CCND1
105,BioPlanet_2019,Signal transduction,7 of 1020,0.0020000578355562,0.0087172332078019,0,0,4.515675528474657,28.06302312769044,ITGB1;APP;JUN;CDKN1A;CCND1;CDK1;CCK
106,BioPlanet_2019,EGF/EGFR signaling pathway,3 of 141,0.0020655143255314,0.0089183889569677,0,0,13.06060606060606,80.74557765734329,JUN;STMN1;FOS
107,BioPlanet_2019,Signal transduction through IL-1R,2 of 38,0.002126086756898,0.009094926682286,0,0,32.56209150326797,200.36992458923652,JUN;FOS
108,BioPlanet_2019,Angiotensin II-mediated activation of JNK pathway via Pyk2-dependent signaling,2 of 39,0.0022384805803649,0.0094878718176937,0,0,31.680445151033386,193.31274432661917,JUN;FOS
109,BioPlanet_2019,Transcriptional activity of SMAD2/SMAD3-SMAD4 heterotrimer,2 of 41,0.0024715423197367,0.0102869599253906,0,0,30.052790346907997,180.4042829225449,RNF111;SMAD7
110,BioPlanet_2019,Fc epsilon receptor I signaling in mast cells,2 of 41,0.0024715423197367,0.0102869599253906,0,0,30.052790346907997,180.4042829225449,JUN;FOS
111,BioPlanet_2019,Innate immune system,4 of 319,0.0025018072144012,0.0103199547594051,0,0,7.7972222222222225,46.71114604574291,APP;JUN;CDK1;FOS
112,BioPlanet_2019,Integrated breast cancer pathway,3 of 152,0.0025568218392305,0.010453554776323,0,0,12.089688834655275,72.16323491018811,JUN;CCND1;SMAD7
113,BioPlanet_2019,Bladder cancer,2 of 42,0.0025921907757449,0.01050519419644,0,0,29.3,174.48888071240097,CDKN1A;CCND1
114,BioPlanet_2019,Integrin signaling pathway,3 of 155,0.002702278311826,0.0108561093918575,0,0,11.849282296650715,70.07262725109973,ITGB1;ACTA1;JUN
115,BioPlanet_2019,ERBB2/ERBB3 signaling events,2 of 44,0.0028416743909962,0.0112209706721388,0,0,27.90196078431373,163.5992917401365,JUN;FOS
116,BioPlanet_2019,HNF3A pathway,2 of 44,0.0028416743909962,0.0112209706721388,0,0,27.90196078431373,163.5992917401365,JUN;FOS
117,BioPlanet_2019,Integrin-linked kinase signaling,2 of 45,0.0029704902359377,0.0114363874083603,0,0,27.251709986320108,158.57847101200235,JUN;CCND1
118,BioPlanet_2019,Interleukin-12/STAT4 pathway,2 of 45,0.0029704902359377,0.0114363874083603,0,0,27.251709986320108,158.57847101200235,JUN;FOS
119,BioPlanet_2019,Interleukin-3 signaling pathway,2 of 45,0.0029704902359377,0.0114363874083603,0,0,27.251709986320108,158.57847101200235,JUN;FOS
120,BioPlanet_2019,ATM pathway,2 of 48,0.0033731185420618,0.0128791798878724,0,0,25.47058823529412,144.97648892699738,JUN;CDKN1A
121,BioPlanet_2019,Angiopoietin receptor Tie2-mediated signaling,2 of 49,0.0035126896593218,0.013194005061843,0,0,24.92740926157697,140.8740938987485,ITGB1;CDKN1A
122,BioPlanet_2019,Interleukin-5 signaling pathway,2 of 49,0.0035126896593218,0.013194005061843,0,0,24.92740926157697,140.8740938987485,JUN;FOS
123,BioPlanet_2019,Interleukin-2 receptor beta chain in T cell activation,2 of 52,0.0039473547117495,0.0147070796518411,0,0,23.42823529411765,129.66847920672666,CCND1;FOS
124,BioPlanet_2019,Androgen receptor regulation of biosynthesis and transcription,2 of 53,0.0040975287076647,0.015144466103529,0,0,22.967704728950405,126.26199945397896,EGR1;JUN
125,BioPlanet_2019,RANKL signaling pathway,2 of 54,0.0042503297911881,0.0155845425676897,0,0,22.524886877828056,123.00297201006306,JUN;FOS
126,BioPlanet_2019,Pre-NOTCH expression and processing,2 of 57,0.004724401633422,0.0170521371456328,0,0,21.29304812834225,114.024578590942,JUN;CCND1
127,BioPlanet_2019,Keratinocyte differentiation,2 of 57,0.004724401633422,0.0170521371456328,0,0,21.29304812834225,114.024578590942,JUN;FOS
128,BioPlanet_2019,Nucleotide excision repair,2 of 58,0.0048876172516927,0.0175044896921087,0,0,20.91176470588235,111.27255319681896,XPC;MNAT1
129,BioPlanet_2019,Caspase cascade in apoptosis,2 of 59,0.0050534131683621,0.0179590529521793,0,0,20.54385964912281,108.62958976497576,ACTA1;APP
130,BioPlanet_2019,RAGE pathway,2 of 60,0.0052217800953762,0.0184157435424719,0,0,20.188640973630832,106.0896310598831,ITGB1;PTGES
131,BioPlanet_2019,FGF signaling pathway,2 of 61,0.0053927087697511,0.0188744806941289,0,0,19.845463609172484,103.6470509502107,JUN;FOS
132,BioPlanet_2019,Endothelins,2 of 64,0.0059207729878119,0.020566895641873,0,0,18.88235294117647,96.85303138215218,JUN;FOS
133,BioPlanet_2019,Gastrin-CREB signaling pathway via PKC and MAPK,3 of 206,0.0059873071197435,0.0206428051441903,0,0,8.849529780564263,45.29289810922548,APP;CDK1;CCK
134,BioPlanet_2019,Glioma,2 of 65,0.0061018564807015,0.0207283653976773,0,0,18.58169934640523,94.75109916063928,CDKN1A;CCND1
135,BioPlanet_2019,LPA receptor mediated events,2 of 65,0.0061018564807015,0.0207283653976773,0,0,18.58169934640523,94.75109916063928,JUN;FOS
136,BioPlanet_2019,Semaphorin interactions,2 of 66,0.0062854557508785,0.0207420039778993,0,0,18.290441176470587,92.72370111910996,ITGB1;CDK5R1
137,BioPlanet_2019,Signaling by TGF-beta receptor complex,2 of 66,0.0062854557508785,0.0207420039778993,0,0,18.290441176470587,92.72370111910996,RNF111;SMAD7
138,BioPlanet_2019,Thyroid-stimulating hormone signaling pathway,2 of 66,0.0062854557508785,0.0207420039778993,0,0,18.290441176470587,92.72370111910996,JUN;FOS
139,BioPlanet_2019,HIF-1 transcriptional activity in hypoxia,2 of 66,0.0062854557508785,0.0207420039778993,0,0,18.290441176470587,92.72370111910996,JUN;FOS
140,BioPlanet_2019,Developmental biology,4 of 420,0.0066405671053482,0.0217584539196518,0,0,5.873798076923077,29.454500618414727,ITGB1;CDK1;PAX6;CDK5R1
141,BioPlanet_2019,Disease,5 of 674,0.0067967668284464,0.0221134244700159,0,0,4.651863638555379,23.218885339668304,APP;CDKN1A;CDK1;MNAT1;ATF4
142,BioPlanet_2019,CDC42 signaling events,2 of 70,0.0070448284785339,0.0227602150844942,0,0,17.21107266435986,85.28880762599312,JUN;PAX6
143,BioPlanet_2019,Rac1 cell motility signaling pathway,2 of 71,0.0072408702404945,0.0229128907610171,0,0,16.96078431372549,83.58298052804865,JUN;CDK5R1
144,BioPlanet_2019,Interleukin-6 signaling pathway,2 of 71,0.0072408702404945,0.0229128907610171,0,0,16.96078431372549,83.58298052804865,JUN;FOS
145,BioPlanet_2019,Melanoma,2 of 71,0.0072408702404945,0.0229128907610171,0,0,16.96078431372549,83.58298052804865,CDKN1A;CCND1
146,BioPlanet_2019,Chronic myeloid leukemia,2 of 73,0.0076403289160953,0.024012462307728,0,0,16.48135874067937,80.33532794767753,CDKN1A;CCND1
147,BioPlanet_2019,E2F transcription factor network,2 of 74,0.0078437278787706,0.0244851505404868,0,0,16.251633986928105,78.78858890769375,CDKN1A;CDK1
148,BioPlanet_2019,Focal adhesion,3 of 233,0.0083957787686855,0.0260325489337767,0,0,7.8,37.28420457044072,ITGB1;JUN;CCND1
149,BioPlanet_2019,Mitochondrial pathway of apoptosis: caspases,2 of 77,0.0084684960541181,0.0260829678466837,0,0,15.59921568627451,74.43013434591808,ACHE;PTMA
150,BioPlanet_2019,Signaling by SCF-KIT,2 of 78,0.0086815795559781,0.0265604258527889,0,0,15.393188854489164,73.06456811678535,CDKN1A;CDK1
151,BioPlanet_2019,Signaling events mediated by hepatocyte growth factor receptor (c-Met),2 of 79,0.0088970620111385,0.0265604258527889,0,0,15.192513368983958,71.73956722387139,EGR1;JUN
152,BioPlanet_2019,p73 transcription factor network,2 of 79,0.0088970620111385,0.0265604258527889,0,0,15.192513368983958,71.73956722387139,CDKN1A;CDK1
153,BioPlanet_2019,Chk1/Chk2(Cds1)-mediated inactivation of cyclin B-Cdk1 complex,1 of 5,0.0089684554827598,0.0265604258527889,0,0,142.57142857142858,672.0876744444516,CDK1
154,BioPlanet_2019,Cyclin B2-mediated events,1 of 5,0.0089684554827598,0.0265604258527889,0,0,142.57142857142858,672.0876744444516,CDK1
155,BioPlanet_2019,ERK activation,1 of 5,0.0089684554827598,0.0265604258527889,0,0,142.57142857142858,672.0876744444516,CDK1
156,BioPlanet_2019,Apoptosis modulation and signaling,2 of 80,0.0091149345910719,0.0266525302599698,0,0,14.996983408748116,70.45344423644089,JUN;FOS
157,BioPlanet_2019,Nuclear beta-catenin signaling and target gene transcription regulation,2 of 80,0.0091149345910719,0.0266525302599698,0,0,14.996983408748116,70.45344423644089,JUN;CCND1
158,BioPlanet_2019,MAP kinase signaling pathway,2 of 81,0.009335188491525,0.0271248873149971,0,0,14.806403574087865,69.20460186885143,JUN;FOS
159,BioPlanet_2019,Response to elevated platelet cytosolic calcium,2 of 83,0.0097828051438365,0.0282478498528281,0,0,14.439360929557008,66.81278586522924,APP;CLU
160,BioPlanet_2019,Small cell lung cancer,2 of 84,0.0100101503968335,0.0287247793996092,0,0,14.262553802008608,65.66701782939222,ITGB1;CCND1
161,BioPlanet_2019,C-Myb transcription factor network,2 of 85,0.0102398419737957,0.0290233557784885,0,0,14.090007087172218,64.55293197222584,CDKN1A;CCND1
162,BioPlanet_2019,Myc active pathway,2 of 85,0.0102398419737957,0.0290233557784885,0,0,14.090007087172218,64.55293197222584,MTA1;PTMA
163,BioPlanet_2019,Mitotic G2-G2/M phases,2 of 87,0.0107062293438032,0.0297471212876996,0,0,13.757093425605536,62.41496334428567,CDK1;MNAT1
164,BioPlanet_2019,Phosphorylation of Emi1,1 of 6,0.010752747305294,0.0297471212876996,0,0,114.05142857142856,516.9488201244333,CDK1
165,BioPlanet_2019,Basic mechanisms of SUMOylation,1 of 6,0.010752747305294,0.0297471212876996,0,0,114.05142857142856,516.9488201244333,SUMO2
166,BioPlanet_2019,Neurotransmitter clearance in the synaptic cleft,1 of 6,0.010752747305294,0.0297471212876996,0,0,114.05142857142856,516.9488201244333,ACHE
167,BioPlanet_2019,FSH regulation of apoptosis,3 of 263,0.011656109620006,0.0320543014550166,0,0,6.8895104895104895,30.67158264624152,KLF10;ACTA1;CLU
168,BioPlanet_2019,Signaling by ERBB4,2 of 93,0.012160803631517,0.0332443270873424,0,0,12.846153846153848,56.6455947582395,CDKN1A;CDK1
169,BioPlanet_2019,Acetylcholine biosynthesis,1 of 7,0.0125339166174689,0.0340627616310039,0,0,95.03809523809524,416.20194419543344,ACHE
170,BioPlanet_2019,Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family,2 of 97,0.0131760117301551,0.0355983474814717,0,0,12.302786377708978,53.263159193779046,JUN;CDK1
171,BioPlanet_2019,Insulin signaling pathway,3 of 277,0.0133950190410228,0.0358795673733243,0,0,6.532846715328467,28.17533399462376,EGR1;JUN;FOS
172,BioPlanet_2019,Wnt signaling pathway and pluripotency,2 of 98,0.0134354224146864,0.0358795673733243,0,0,12.174019607843135,52.46832740335703,JUN;CCND1
173,BioPlanet_2019,Senescence and autophagy,2 of 99,0.013697059712945,0.0361602376421749,0,0,12.047907822922983,51.69244112778035,JUN;CDKN1A
174,BioPlanet_2019,Granule cell survival pathway,2 of 99,0.013697059712945,0.0361602376421749,0,0,12.047907822922983,51.69244112778035,JUN;FOS
175,BioPlanet_2019,GnRH signaling pathway,2 of 101,0.0142269806187647,0.037146794788315,0,0,11.803327391562686,50.19500798398928,JUN;ATF4
176,BioPlanet_2019,CHL1 interactions,1 of 8,0.0143119685548053,0.037146794788315,0,0,81.45714285714286,345.92071940977723,ITGB1
177,BioPlanet_2019,Formyl peptide interaction with formyl peptide receptors,1 of 8,0.0143119685548053,0.037146794788315,0,0,81.45714285714286,345.92071940977723,APP
178,BioPlanet_2019,Signaling by ERBB2,2 of 102,0.0144952475181609,0.0374123148234098,0,0,11.684705882352942,49.472278664136425,CDKN1A;CDK1
179,BioPlanet_2019,Chagas disease,2 of 104,0.0150383525901269,0.0385984383146591,0,0,11.45444059976932,48.07602256434972,JUN;FOS
180,BioPlanet_2019,DNA repair,2 of 105,0.0153131741809413,0.039086665588922,0,0,11.342661336379212,47.401455434002834,XPC;MNAT1
181,BioPlanet_2019,Alpha-4 beta-7 integrin signaling,1 of 9,0.0160869082852461,0.0406128504250475,0,0,71.27142857142857,294.3331456349383,ITGB1
182,BioPlanet_2019,G2/M DNA damage checkpoint,1 of 9,0.0160869082852461,0.0406128504250475,0,0,71.27142857142857,294.3331456349383,CDK1
183,BioPlanet_2019,Signaling by EGFR in cancer,2 of 111,0.0170073515117543,0.0424724129644891,0,0,10.715056664867785,43.65431507859349,CDKN1A;CDK1
184,BioPlanet_2019,Epidermal growth factor receptor (EGFR) pathway,2 of 111,0.0170073515117543,0.0424724129644891,0,0,10.715056664867785,43.65431507859349,ACTA1;JUN
185,BioPlanet_2019,Activation of Src by protein tyrosine phosphatase alpha,1 of 10,0.0178587410119325,0.0434249386711201,0,0,63.34920634920635,254.99716559529236,CDK1
186,BioPlanet_2019,Apoptotic DNA fragmentation and tissue homeostasis,1 of 10,0.0178587410119325,0.0434249386711201,0,0,63.34920634920635,254.99716559529236,TOP2A
187,BioPlanet_2019,Cdc25 and Chk1 regulatory pathway in response to DNA damage,1 of 10,0.0178587410119325,0.0434249386711201,0,0,63.34920634920635,254.99716559529236,CDK1
188,BioPlanet_2019,Splicing regulation through Sam68,1 of 10,0.0178587410119325,0.0434249386711201,0,0,63.34920634920635,254.99716559529236,CDK1
189,BioPlanet_2019,E2F-enabled inhibition of pre-replication complex formation,1 of 10,0.0178587410119325,0.0434249386711201,0,0,63.34920634920635,254.99716559529236,CDK1
190,BioPlanet_2019,Cell cycle checkpoints,2 of 117,0.01877782369124,0.0454207044259314,0,0,10.152941176470588,40.35874017540217,CDKN1A;CDK1
191,BioPlanet_2019,Prolactin regulation of apoptosis,2 of 118,0.0190801973109532,0.0459117247794813,0,0,10.064908722109534,39.84802311668438,EGR1;CCND1
192,BioPlanet_2019,Signaling by NOTCH,2 of 119,0.0193846338288839,0.0460299088134015,0,0,9.978381096028157,39.34749669956984,JUN;CCND1
193,BioPlanet_2019,Recruitment of NuMA to mitotic centrosomes,1 of 11,0.0196274719399136,0.0460299088134015,0,0,57.011428571428574,224.10195239289595,CDK1
194,BioPlanet_2019,Cardiac protection against reactive oxygen species,1 of 11,0.0196274719399136,0.0460299088134015,0,0,57.011428571428574,224.10195239289595,SOD2
195,BioPlanet_2019,Glutathione biosynthesis and recycling,1 of 11,0.0196274719399136,0.0460299088134015,0,0,57.011428571428574,224.10195239289595,GCLC
196,BioPlanet_2019,Monocyte and its surface molecules,1 of 11,0.0196274719399136,0.0460299088134015,0,0,57.011428571428574,224.10195239289595,ITGB1
197,BioPlanet_2019,Notch signaling pathway,2 of 121,0.0199996637126265,0.0466658819961286,0,0,9.809688581314878,38.375892351296685,CDKN1A;CCND1
198,BioPlanet_2019,Signaling by PDGF,2 of 122,0.0203102412069003,0.0471524192843616,0,0,9.727450980392156,37.90427757828709,CDKN1A;CDK1
199,BioPlanet_2019,Axon guidance,3 of 325,0.0204364854536051,0.0472082813978279,0,0,5.545454545454546,21.574221986473628,ITGB1;CDK1;CDK5R1
200,BioPlanet_2019,Interleukin-1 signaling pathway,2 of 125,0.0212541291083117,0.0482127566102971,0,0,9.488761358201817,36.54315656605238,JUN;FOS
201,BioPlanet_2019,Activation of chaperones by ATF6 alpha,1 of 12,0.0213931062881188,0.0482127566102971,0,0,51.82597402597403,199.25462501506232,ATF4
202,BioPlanet_2019,Rab GTPases mark targets in the endocytotic machinery,1 of 12,0.0213931062881188,0.0482127566102971,0,0,51.82597402597403,199.25462501506232,ACTA1
203,BioPlanet_2019,Salmonella infection,1 of 12,0.0213931062881188,0.0482127566102971,0,0,51.82597402597403,199.25462501506232,ACTA1
204,BioPlanet_2019,D4-GDI signaling pathway,1 of 12,0.0213931062881188,0.0482127566102971,0,0,51.82597402597403,199.25462501506232,JUN
205,BioPlanet_2019,Neurotrophin signaling pathway,2 of 126,0.0215727840035996,0.0483816806294321,0,0,9.411764705882351,36.10656713969488,JUN;ATF4
206,BioPlanet_2019,Signaling by FGFR in disease,2 of 128,0.0222160852218876,0.0495837264372564,0,0,9.261437908496733,35.257726325987456,CDKN1A;CDK1
462,Panther_2016,CCKR signaling map ST Homo sapiens P06959,6 of 165,4.5670719127344563e-07,1.3244508546929925e-05,0,0,24.91194968553459,363.6951180591245,ITGB1;JUN;CCND1;CCK;FOS;CLU
463,Panther_2016,Apoptosis signaling pathway Homo sapiens P00006,3 of 102,0.0008136745080742181,0.0117982803670761,0,0,18.241505968778696,129.76916392509293,JUN;FOS;ATF4
464,Panther_2016,Huntington disease Homo sapiens P00029,3 of 124,0.0014303502494726,0.0138267190782354,0,0,14.908339594290007,97.64717840585745,ACTA1;JUN;FOS
465,Panther_2016,Inflammation mediated by chemokine and cytokine signaling pathway Homo sapiens P00031,3 of 188,0.0046460834151383,0.027401529473848,0,0,9.71941031941032,52.21005470741969,ITGB1;ACTA1;JUN
466,Panther_2016,B cell activation Homo sapiens P00010,2 of 57,0.004724401633422,0.027401529473848,0,0,21.29304812834225,114.024578590942,JUN;FOS
467,Panther_2016,Nicotinic acetylcholine receptor signaling pathway Homo sapiens P00044,2 of 68,0.0066601651535454,0.0276961923208454,0,0,17.73440285204991,88.87792835692386,ACTA1;ACHE
468,Panther_2016,Cytoskeletal regulation by Rho GTPase Homo sapiens P00016,2 of 70,0.0070448284785339,0.0276961923208454,0,0,17.21107266435986,85.28880762599312,ACTA1;STMN1
469,Panther_2016,T cell activation Homo sapiens P00053,2 of 73,0.0076403289160953,0.0276961923208454,0,0,16.48135874067937,80.33532794767753,JUN;FOS
470,Panther_2016,Interleukin signaling pathway Homo sapiens P00036,2 of 86,0.0104718711803138,0.03173443266797,0,0,13.92156862745098,63.46930219166045,CDKN1A;FOS
471,Panther_2016,TGF-beta signaling pathway Homo sapiens P00052,2 of 88,0.0109429078165413,0.03173443266797,0,0,13.596443228454172,61.38880754927296,JUN;SMAD7
472,Panther_2016,Alzheimer disease-presenilin pathway Homo sapiens P00004,2 of 99,0.013697059712945,0.0361104301523096,0,0,12.047907822922983,51.69244112778035,ACTA1;APP
473,Panther_2016,PDGF signaling pathway Homo sapiens P00047,2 of 112,0.0172971793032696,0.0418015166495683,0,0,10.61711229946524,43.07587369429739,JUN;FOS
491,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,6 of 219,2.3826826434546825e-06,0.0003264275221532915,0,0,18.545539906103286,240.11436363967388,EGR1;JUN;CDKN1A;CCND1;FOS;ATF4
492,KEGG_2019_Human,Colorectal cancer,4 of 86,1.689711449646759e-05,0.001157452343008,0,0,30.307926829268293,333.0346439357679,JUN;CDKN1A;CCND1;FOS
493,KEGG_2019_Human,Viral carcinogenesis,5 of 201,2.854206744570107e-05,0.0013034210800203,0,0,16.267281105990783,170.22296877484598,JUN;CDKN1A;CCND1;CDK1;ATF4
494,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",4 of 106,3.852944945362921e-05,0.0013196336437868,0,0,24.340686274509803,247.4008696850819,EGR1;CDKN1A;FOS;ATF4
495,KEGG_2019_Human,Cocaine addiction,3 of 49,9.321226877020766e-05,0.0025540161643036,0,0,39.36363636363637,365.3193920089891,JUN;CDK5R1;ATF4
496,KEGG_2019_Human,Breast cancer,4 of 147,0.0001374226610792424,0.0031372729374529,0,0,17.32604895104895,154.07101124241234,JUN;CDKN1A;CCND1;FOS
497,KEGG_2019_Human,Oxytocin signaling pathway,4 of 153,0.0001602986172421193,0.0031372729374529,0,0,16.623322147651006,145.26243720298163,JUN;CDKN1A;CCND1;FOS
498,KEGG_2019_Human,Hepatitis B,4 of 163,0.0002043731196088013,0.0034998896733007,0,0,15.56996855345912,132.27565213332966,JUN;CDKN1A;FOS;ATF4
499,KEGG_2019_Human,Amphetamine addiction,3 of 68,0.0002476705405233624,0.0036252810256621,0,0,27.83076923076923,231.0903198395103,JUN;FOS;ATF4
500,KEGG_2019_Human,p53 signaling pathway,3 of 72,0.0002932857800566364,0.0036252810256621,0,0,26.21212121212121,213.21891066271564,CDKN1A;CCND1;CDK1
501,KEGG_2019_Human,Leishmaniasis,3 of 74,0.0003179926173270372,0.0036252810256621,0,0,25.471190781049938,205.1317864433363,ITGB1;JUN;FOS
502,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,4 of 186,0.0003380368211563428,0.0036252810256621,0,0,13.586538461538462,108.58844852505952,JUN;CDKN1A;CCND1;FOS
503,KEGG_2019_Human,Pertussis,3 of 76,0.00034400476885845566,0.0036252810256621,0,0,24.770859277708592,197.5440118996446,ITGB1;JUN;FOS
504,KEGG_2019_Human,GnRH signaling pathway,3 of 93,0.0006218147950602794,0.0056792417948838,0,0,20.074747474747475,148.20921609335653,EGR1;JUN;ATF4
505,KEGG_2019_Human,Small cell lung cancer,3 of 93,0.0006218147950602794,0.0056792417948838,0,0,20.074747474747475,148.20921609335653,ITGB1;CDKN1A;CCND1
506,KEGG_2019_Human,Prostate cancer,3 of 97,0.0007030288119836389,0.0060196842026099,0,0,19.216634429400383,139.51493133900632,CDKN1A;CCND1;ATF4
507,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,3 of 100,0.0007681770335999374,0.0061906031531289,0,0,18.619493908153704,133.5295206771706,EGR1;JUN;CCND1
508,KEGG_2019_Human,TNF signaling pathway,3 of 110,0.00101272030596,0.0076926650947434,0,0,16.87085811384877,116.32651015910756,JUN;FOS;ATF4
509,KEGG_2019_Human,Cholinergic synapse,3 of 112,0.0010668659620447,0.0076926650947434,0,0,16.559633027522935,113.31806453452602,ACHE;FOS;ATF4
510,KEGG_2019_Human,Cell cycle,3 of 124,0.0014303502494726,0.0097978992088875,0,0,14.908339594290007,97.64717840585745,CDKN1A;CCND1;CDK1
511,KEGG_2019_Human,Relaxin signaling pathway,3 of 130,0.0016379095734853,0.0098662701836812,0,0,14.199713672154616,91.08171330477232,JUN;FOS;ATF4
512,KEGG_2019_Human,FoxO signaling pathway,3 of 132,0.0017110631546693,0.0098662701836812,0,0,13.97815362931642,89.0497898618709,CDKN1A;CCND1;SOD2
513,KEGG_2019_Human,MAPK signaling pathway,4 of 295,0.0018836478564689,0.0098662701836812,0,0,8.450601374570446,53.02367888067882,JUN;STMN1;FOS;ATF4
514,KEGG_2019_Human,Estrogen signaling pathway,3 of 137,0.0019028193851738,0.0098662701836812,0,0,13.453188602442332,84.27640498778267,JUN;FOS;ATF4
515,KEGG_2019_Human,Measles,3 of 138,0.0019427115957795,0.0098662701836812,0,0,13.352861952861954,83.37087096052153,JUN;CCND1;FOS
516,KEGG_2019_Human,MicroRNAs in cancer,4 of 299,0.0019783360320314,0.0098662701836812,0,0,8.334322033898305,51.88531495007222,CDKN1A;CCND1;STMN1;EZH2
517,KEGG_2019_Human,Fluid shear stress and atherosclerosis,3 of 139,0.0019831232067241,0.0098662701836812,0,0,13.254010695187166,82.480799359837,JUN;SUMO2;FOS
518,KEGG_2019_Human,Thyroid cancer,2 of 37,0.0020164639791465,0.0098662701836812,0,0,33.49411764705882,207.87822023706013,CDKN1A;CCND1
519,KEGG_2019_Human,Apoptosis,3 of 143,0.002150011968953,0.010156953094709,0,0,12.872727272727271,79.06791934348087,JUN;FOS;ATF4
520,KEGG_2019_Human,Pathways in cancer,5 of 530,0.0024520547006497,0.0109226225098041,0,0,5.972043010752688,35.89692903503908,ITGB1;JUN;CDKN1A;CCND1;FOS
521,KEGG_2019_Human,Bladder cancer,2 of 41,0.0024715423197367,0.0109226225098041,0,0,30.052790346907997,180.4042829225449,CDKN1A;CCND1
522,KEGG_2019_Human,Cushing syndrome,3 of 155,0.002702278311826,0.011569129022505,0,0,11.849282296650715,70.07262725109973,CDKN1A;CCND1;ATF4
523,KEGG_2019_Human,Cellular senescence,3 of 160,0.0029559030440835,0.0122714762739227,0,0,11.469021424435438,66.79501966705834,CDKN1A;CCND1;CDK1
524,KEGG_2019_Human,Nucleotide excision repair,2 of 47,0.0032362218959433,0.0130400705807129,0,0,26.037908496732022,149.28440911892838,XPC;MNAT1
525,KEGG_2019_Human,Tight junction,3 of 170,0.0035060842957602,0.0137238156719759,0,0,10.776810016330977,60.924059952901125,ITGB1;JUN;CCND1
526,KEGG_2019_Human,PI3K-Akt signaling pathway,4 of 354,0.0036353556168395,0.0138345477640837,0,0,7.005,39.347423631956815,ITGB1;CDKN1A;CCND1;ATF4
527,KEGG_2019_Human,Glutathione metabolism,2 of 56,0.0045637756240171,0.016898304337577,0,0,21.688453159041394,116.89219581217986,GCLC;CHAC1
528,KEGG_2019_Human,Endometrial cancer,2 of 58,0.0048876172516927,0.0176211464074184,0,0,20.91176470588235,111.27255319681896,CDKN1A;CCND1
529,KEGG_2019_Human,Focal adhesion,3 of 199,0.0054412023953382,0.018692197080926,0,0,9.168831168831169,47.80404131262037,ITGB1;JUN;CCND1
530,KEGG_2019_Human,Epstein-Barr virus infection,3 of 201,0.0055940151848026,0.018692197080926,0,0,9.075298438934803,47.0650237968777,JUN;CDKN1A;CCND1
531,KEGG_2019_Human,Proteoglycans in cancer,3 of 201,0.0055940151848026,0.018692197080926,0,0,9.075298438934803,47.0650237968777,ITGB1;CDKN1A;CCND1
532,KEGG_2019_Human,Mitophagy,2 of 65,0.0061018564807015,0.0199036747108598,0,0,18.58169934640523,94.75109916063928,JUN;ATF4
533,KEGG_2019_Human,Non-small cell lung cancer,2 of 66,0.0062854557508785,0.0200257543690782,0,0,18.290441176470587,92.72370111910996,CDKN1A;CCND1
534,KEGG_2019_Human,Human immunodeficiency virus 1 infection,3 of 212,0.0064806969211088,0.0201785335952707,0,0,8.592866463679862,43.29882876331256,JUN;CDK1;FOS
535,KEGG_2019_Human,Renal cell carcinoma,2 of 69,0.0068512571060586,0.0208582716340007,0,0,17.46883230904302,87.0528360021458,JUN;CDKN1A
536,KEGG_2019_Human,Prolactin signaling pathway,2 of 70,0.0070448284785339,0.0209813369904162,0,0,17.21107266435986,85.28880762599312,CCND1;FOS
537,KEGG_2019_Human,B cell receptor signaling pathway,2 of 71,0.0072408702404945,0.0211063664456969,0,0,16.96078431372549,83.58298052804865,JUN;FOS
538,KEGG_2019_Human,Melanoma,2 of 72,0.0074393733819704,0.0212332115277072,0,0,16.71764705882353,81.93266424635078,CDKN1A;CCND1
539,KEGG_2019_Human,Human cytomegalovirus infection,3 of 225,0.0076312864486605,0.0213364539482956,0,0,8.084357084357084,39.41527361829134,CDKN1A;CCND1;ATF4
540,KEGG_2019_Human,Glioma,2 of 75,0.0080495613315453,0.0216233314200334,0,0,16.028203062046735,77.29020196043888,CDKN1A;CCND1
541,KEGG_2019_Human,Pancreatic cancer,2 of 75,0.0080495613315453,0.0216233314200334,0,0,16.028203062046735,77.29020196043888,CDKN1A;CCND1
542,KEGG_2019_Human,Chronic myeloid leukemia,2 of 76,0.0082578203549345,0.0217561805505007,0,0,15.81081081081081,75.83804984876704,CDKN1A;CCND1
543,KEGG_2019_Human,ErbB signaling pathway,2 of 85,0.0102398419737957,0.0260844791218726,0,0,14.090007087172218,64.55293197222584,JUN;CDKN1A
544,KEGG_2019_Human,Insulin secretion,2 of 86,0.0104718711803138,0.0260844791218726,0,0,13.92156862745098,63.46930219166045,CCK;ATF4
545,KEGG_2019_Human,Salmonella infection,2 of 86,0.0104718711803138,0.0260844791218726,0,0,13.92156862745098,63.46930219166045,JUN;FOS
546,KEGG_2019_Human,Rheumatoid arthritis,2 of 91,0.0116667789265867,0.0285419413025424,0,0,13.13615333773959,58.4691483430762,JUN;FOS
547,KEGG_2019_Human,Th1 and Th2 cell differentiation,2 of 92,0.0119126525829231,0.0286321649800082,0,0,12.98954248366013,57.5456762088212,JUN;FOS
548,KEGG_2019_Human,IL-17 signaling pathway,2 of 93,0.012160803631517,0.0287246568537557,0,0,12.846153846153848,56.6455947582395,JUN;FOS
549,KEGG_2019_Human,Choline metabolism in cancer,2 of 99,0.013697059712945,0.0318050369605673,0,0,12.047907822922983,51.69244112778035,JUN;FOS
550,KEGG_2019_Human,T cell receptor signaling pathway,2 of 101,0.0142269806187647,0.0324849390795129,0,0,11.803327391562686,50.19500798398928,JUN;FOS
551,KEGG_2019_Human,Longevity regulating pathway,2 of 102,0.0144952475181609,0.0325549001637385,0,0,11.684705882352942,49.472278664136425,SOD2;ATF4
552,KEGG_2019_Human,Chagas disease (American trypanosomiasis),2 of 103,0.014765707607644,0.0326274506814069,0,0,11.568433313919629,48.76612722849258,JUN;FOS
553,KEGG_2019_Human,Toll-like receptor signaling pathway,2 of 104,0.0150383525901269,0.0327024492832918,0,0,11.45444059976932,48.07602256434972,JUN;FOS
554,KEGG_2019_Human,Th17 cell differentiation,2 of 107,0.0158693141798747,0.0339702506662944,0,0,11.125490196078433,46.09699962057723,JUN;FOS
555,KEGG_2019_Human,Neurotrophin signaling pathway,2 of 119,0.0193846338288839,0.0408568436085708,0,0,9.978381096028157,39.34749669956984,JUN;ATF4
556,KEGG_2019_Human,Human papillomavirus infection,3 of 330,0.0212672909815595,0.0441457403708129,0,0,5.459271615234918,21.021389508453684,ITGB1;CDKN1A;CCND1
557,KEGG_2019_Human,Osteoclast differentiation,2 of 127,0.0218934386440505,0.044767180510969,0,0,9.336,35.67816157733114,JUN;FOS
558,KEGG_2019_Human,Dopaminergic synapse,2 of 131,0.0231958988654078,0.046732913890601,0,0,9.04468764249886,34.04221254646382,FOS;ATF4
628,Reactome_2022,Generic Transcription Pathway R-HSA-212436,13 of 1190,7.006918867080885e-08,1.5584579642765683e-05,0,0,9.021868420080528,148.6242996610414,JUN;BTG2;CDKN1A;ARID3A;FOS;YBX1;SMAD7;CCND1;CDK1;MNAT1;RNF111;CDK5R1;EZH2
629,Reactome_2022,Gene Expression (Transcription) R-HSA-74160,14 of 1449,8.58654525772214e-08,1.5584579642765683e-05,0,0,8.216851441241685,133.69215212960455,JUN;BTG2;CDKN1A;ARID3A;FOS;YBX1;SMAD7;MTA1;CCND1;CDK1;MNAT1;RNF111;CDK5R1;EZH2
630,Reactome_2022,Transcriptional Regulation By TP53 R-HSA-3700989,8 of 354,1.7477993347281432e-07,1.983561145976628e-05,0,0,16.199834847233692,252.06518873976825,JUN;BTG2;CDKN1A;CDK1;ARID3A;FOS;MNAT1;CDK5R1
631,Reactome_2022,RNA Polymerase II Transcription R-HSA-73857,13 of 1312,2.1857423096161186e-07,1.983561145976628e-05,0,0,8.121464671821133,124.55192043279516,JUN;BTG2;CDKN1A;ARID3A;FOS;YBX1;SMAD7;CCND1;CDK1;MNAT1;RNF111;CDK5R1;EZH2
632,Reactome_2022,Formation Of Incision Complex In GG-NER R-HSA-5696395,4 of 42,9.421993008949018e-07,6.840366924496987e-05,0,0,65.54605263157895,909.4546928504016,SUMO2;XPC;MNAT1;RNF111
633,Reactome_2022,Nucleotide Excision Repair R-HSA-5696398,5 of 108,1.3799069774350415e-06,8.348437213482002e-05,0,0,31.10084559974945,419.65908807282494,SUMO2;XPC;MNAT1;RNF111;HMGN1
634,Reactome_2022,TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,4 of 49,1.7676200942917235e-06,9.166372774684225e-05,0,0,55.33055555555556,732.9017053236411,BTG2;CDKN1A;CDK1;ARID3A
635,Reactome_2022,Regulation Of PTEN Gene Transcription R-HSA-8943724,4 of 61,4.287354855514025e-06,0.0001945387265689489,0,0,43.655701754385966,539.5775149211091,EGR1;JUN;MTA1;EZH2
636,Reactome_2022,Mitotic G1 Phase And G1/S Transition R-HSA-453279,5 of 147,6.285614784075377e-06,0.00025285736369221414,0,0,22.514766015447524,269.6649115310272,TOP2A;CDKN1A;CCND1;CDK1;MNAT1
637,Reactome_2022,Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,3 of 21,6.965767594826836e-06,0.00025285736369221414,0,0,100.73737373737374,1196.206221408139,APP;JUN;CDK5R1
638,Reactome_2022,Diseases Of Programmed Cell Death R-HSA-9645723,4 of 71,7.881090984098276e-06,0.00026007600247524314,0,0,37.12126865671642,436.2136692618441,APP;JUN;CDK5R1;EZH2
639,Reactome_2022,Signal Transduction R-HSA-162582,15 of 2465,9.633381814327756e-06,0.00029140979988341456,0,0,5.106122448979592,58.97712469322755,ITGB1;EGR1;APP;JUN;CDKN1A;FOS;YBX1;SMAD7;MTA1;CCND1;STMN1;CDK1;RNF111;CDK5R1;EZH2
640,Reactome_2022,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,3 of 24,1.0561305190162971e-05,0.0002949041372330122,0,0,86.33333333333333,989.234415216844,APP;JUN;CDK5R1
641,Reactome_2022,Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,4 of 82,1.3988659786163267e-05,0.000362705964455519,0,0,31.868589743589745,356.20362722766305,SUMO2;XPC;MNAT1;RNF111
642,Reactome_2022,Signaling By TGF-beta Receptor Complex R-HSA-170834,4 of 91,2.1130827669003523e-05,0.0005113660295898852,0,0,28.558908045977013,307.43029237938373,ITGB1;YBX1;RNF111;SMAD7
643,Reactome_2022,Cytokine Signaling In Immune System R-HSA-1280215,8 of 702,2.801154933610431e-05,0.0006355120255628665,0,0,7.9333058871963775,83.16400196031876,ITGB1;EGR1;APP;JUN;CDKN1A;CCND1;FOS;SMAD7
644,Reactome_2022,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,3 of 36,3.67082721973702e-05,0.0007838295769203166,0,0,54.90633608815427,560.7314200415044,YBX1;RNF111;SMAD7
645,Reactome_2022,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,4 of 107,3.997457696812567e-05,0.0008061539688572011,0,0,24.103155339805824,244.09908681755397,ITGB1;CDKN1A;CCND1;FOS
646,Reactome_2022,NGF-stimulated Transcription R-HSA-9031628,3 of 39,4.681167930207018e-05,0.000894349451929025,0,0,50.323232323232325,501.6913165785911,EGR1;FOS;CDK5R1
647,Reactome_2022,Signaling By TGFB Family Members R-HSA-9006936,4 of 119,6.057300576276312e-05,0.0010994000545941,0,0,21.575,209.52909068321375,ITGB1;YBX1;RNF111;SMAD7
648,Reactome_2022,Cyclin D Associated Events In G1 R-HSA-69231,3 of 47,8.223927228069132e-05,0.0013680768337957,0,0,41.15702479338843,387.1179377935321,CDKN1A;CCND1;MNAT1
649,Reactome_2022,G1/S Transition R-HSA-69206,4 of 129,8.291374750277433e-05,0.0013680768337957,0,0,19.839,186.44116228617156,CDKN1A;CCND1;CDK1;MNAT1
650,Reactome_2022,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,3 of 51,0.00010509960440120591,0.0016216975368818,0,0,37.71969696969697,345.53513316386227,YBX1;RNF111;SMAD7
651,Reactome_2022,PTEN Regulation R-HSA-6807070,4 of 139,0.0001107268477732558,0.0016216975368818,0,0,18.360185185185184,167.2327226344515,EGR1;JUN;MTA1;EZH2
652,Reactome_2022,PIP3 Activates AKT Signaling R-HSA-1257604,5 of 268,0.00011168715818745293,0.0016216975368818,0,0,12.082055685023915,109.94439695259656,EGR1;JUN;CDKN1A;MTA1;EZH2
653,Reactome_2022,Activation Of AP-1 Family Of Transcription Factors R-HSA-450341,2 of 10,0.00014047193487328206,0.0019216154875364,0,0,146.73529411764707,1301.6158433360367,JUN;FOS
654,Reactome_2022,Signaling By Interleukins R-HSA-449147,6 of 453,0.00014293007758535653,0.0019216154875364,0,0,8.732438478747204,77.30963151324484,ITGB1;APP;JUN;CDKN1A;CCND1;FOS
655,Reactome_2022,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,3 of 61,0.00017940461925568406,0.0023258527424933,0,0,31.20062695924765,269.1324541087196,EGR1;FOS;CDK5R1
656,Reactome_2022,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,3 of 62,0.0001882942147487652,0.0023569241363379,0,0,30.67026194144838,263.07432044187647,JUN;FOS;MNAT1
657,Reactome_2022,Glutathione Synthesis And Recycling R-HSA-174403,2 of 12,0.0002055597839412204,0.0024218348566625,0,0,117.37647058823528,996.4996667678744,GCLC;CHAC1
658,Reactome_2022,Intracellular Signaling By Second Messengers R-HSA-9006925,5 of 306,0.00020730687947149849,0.0024218348566625,0,0,10.536384096024006,89.36234351686781,EGR1;JUN;CDKN1A;MTA1;EZH2
659,Reactome_2022,Cellular Senescence R-HSA-2559583,4 of 165,0.00021413889147348883,0.0024218348566625,0,0,15.375,129.90161806633006,JUN;CDKN1A;FOS;EZH2
660,Reactome_2022,DNA Repair R-HSA-73894,5 of 310,0.00022016680515113843,0.0024218348566625,0,0,10.396086726599682,87.54674680935736,SUMO2;XPC;MNAT1;RNF111;HMGN1
661,Reactome_2022,SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,4 of 168,0.0002294128534927725,0.0024493195828787,0,0,15.091463414634148,126.46627211403474,TOP2A;MTA1;SUMO2;XPC
662,Reactome_2022,Cellular Responses To Stress R-HSA-2262752,7 of 722,0.00025959868480051647,0.0026448062082412,0,0,6.498336146612009,53.65269126085381,JUN;GCLC;CDKN1A;FOS;CHAC1;ATF4;EZH2
663,Reactome_2022,SUMOylation R-HSA-2990846,4 of 174,0.0002622948305693787,0.0026448062082412,0,0,14.554411764705884,120.01628166415964,TOP2A;MTA1;SUMO2;XPC
664,Reactome_2022,TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,2 of 14,0.000282782621321006,0.0027743267983655,0,0,97.80392156862744,799.139419708988,CDKN1A;ARID3A
665,Reactome_2022,Cellular Responses To Stimuli R-HSA-8953897,7 of 736,0.0002917992481697108,0.002787450712779,0,0,6.3689040253535785,51.83934083003311,JUN;GCLC;CDKN1A;FOS;CHAC1;ATF4;EZH2
666,Reactome_2022,Response Of EIF2AK1 (HRI) To Heme Deficiency R-HSA-9648895,2 of 15,0.0003259186256199044,0.003033550284616,0,0,90.27601809954751,724.8137654755144,CHAC1;ATF4
667,Reactome_2022,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,3 of 81,0.00041493511360315554,0.0037178202756069,0,0,23.177156177156174,180.48951722204924,JUN;CDKN1A;FOS
668,Reactome_2022,Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,2 of 17,0.0004211879595115378,0.0037178202756069,0,0,78.23137254901961,608.0479736697338,CDKN1A;CCND1
669,Reactome_2022,Cyclin E Associated Events During G1/S Transition R-HSA-69202,3 of 82,0.000430161023623949,0.0037178202756069,0,0,22.88262370540852,177.37124690199752,CDKN1A;CCND1;MNAT1
670,Reactome_2022,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,3 of 84,0.00046168069209550543,0.0038974439821085,0,0,22.31537598204265,171.39630351848535,CDKN1A;CCND1;MNAT1
671,Reactome_2022,SUMOylation Of Transcription Factors R-HSA-3232118,2 of 19,0.0005283848977383165,0.0043591754063411,0,0,69.02076124567473,520.8089619438341,MTA1;SUMO2
672,Reactome_2022,Activation Of HOX Genes During Differentiation R-HSA-5619507,3 of 91,0.0005835715305037674,0.0047074770127303,0,0,20.53305785123967,152.89620238017142,JUN;PAX6;EZH2
673,Reactome_2022,Oxidative Stress Induced Senescence R-HSA-2559580,3 of 93,0.0006218147950602794,0.0049069297958017,0,0,20.074747474747475,148.20921609335653,JUN;FOS;EZH2
674,Reactome_2022,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,3 of 96,0.000682126294766358,0.0052683371276635,0,0,19.424242424242426,141.60847168791395,APP;JUN;FOS
675,Reactome_2022,Disease R-HSA-1643685,10 of 1736,0.000734273953092919,0.0055529467702651,0,0,4.064087708351903,29.329010637546197,ITGB1;APP;JUN;GCLC;CDKN1A;MTA1;CCND1;MNAT1;CDK5R1;EZH2
676,Reactome_2022,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,3 of 101,0.0007907171584833318,0.0058081494904704,0,0,18.428571428571427,131.6273656441415,APP;JUN;FOS
677,Reactome_2022,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,3 of 102,0.0008136745080742181,0.0058081494904704,0,0,18.241505968778696,129.76916392509293,APP;JUN;FOS
678,Reactome_2022,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,3 of 103,0.0008370521731680693,0.0058081494904704,0,0,18.05818181818182,127.95348930224206,APP;JUN;FOS
679,Reactome_2022,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,3 of 103,0.0008370521731680693,0.0058081494904704,0,0,18.05818181818182,127.95348930224206,APP;JUN;FOS
680,Reactome_2022,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,2 of 24,0.0008480218264323183,0.0058081494904704,0,0,53.32085561497326,377.1173065055224,CCND1;FOS
681,Reactome_2022,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,3 of 106,0.0009097376837352594,0.0060596830599399,0,0,17.529567519858784,122.74824179232586,APP;JUN;FOS
682,Reactome_2022,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,2 of 25,0.0009207209919278048,0.0060596830599399,0,0,51.0,356.5080289062332,CDK1;MNAT1
683,Reactome_2022,MyD88-independent TLR4 Cascade R-HSA-166166,3 of 107,0.000934827138723514,0.0060596830599399,0,0,17.36013986013986,121.0895608683445,APP;JUN;FOS
684,Reactome_2022,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,3 of 112,0.0010668659620447,0.0067268283047037,0,0,16.559633027522935,113.31806453452602,APP;JUN;FOS
685,Reactome_2022,G0 And Early G1 R-HSA-1538133,2 of 27,0.0010748100321565,0.0067268283047037,0,0,46.91529411764706,320.6947168320981,TOP2A;CDK1
686,Reactome_2022,Signaling By NTRK1 (TRKA) R-HSA-187037,3 of 114,0.0011228123475389,0.0069081505450279,0,0,16.25962325962326,110.4340395393208,EGR1;FOS;CDK5R1
687,Reactome_2022,Epigenetic Regulation Of Gene Expression R-HSA-212165,3 of 116,0.0011805824689738,0.0071425239372916,0,0,15.970233306516493,107.6672779855614,MTA1;MNAT1;EZH2
688,Reactome_2022,FCERI Mediated MAPK Activation R-HSA-2871796,2 of 29,0.0012404195444664,0.0073216913474162,0,0,43.43572984749456,290.6851787186678,JUN;FOS
689,Reactome_2022,Transcriptional Regulation By RUNX2 R-HSA-8878166,3 of 119,0.0012707067627747,0.0073216913474162,0,0,15.554858934169278,103.72263078017762,CDKN1A;CCND1;CDK1
690,Reactome_2022,Estrogen-dependent Gene Expression R-HSA-9018519,3 of 119,0.0012707067627747,0.0073216913474162,0,0,15.554858934169278,103.72263078017762,JUN;CCND1;FOS
691,Reactome_2022,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,2 of 30,0.00132751939454,0.0075295240659067,0,0,41.88235294117647,277.4472679372888,JUN;FOS
692,Reactome_2022,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,2 of 31,0.0014174693130427,0.0079160209328388,0,0,40.43610547667343,265.2156512854863,RNF111;SMAD7
693,Reactome_2022,Signaling By NTRKs R-HSA-166520,3 of 132,0.0017110631546693,0.0094108473506814,0,0,13.97815362931642,89.0497898618709,EGR1;FOS;CDK5R1
694,Reactome_2022,Immune System R-HSA-168256,10 of 1943,0.0017501376612483,0.0094820891198979,0,0,3.587687532333161,22.77485869632857,ITGB1;EGR1;APP;JUN;CDKN1A;CCND1;FOS;CLU;RNF111;SMAD7
695,Reactome_2022,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,5 of 496,0.001836972514601,0.0098061915117674,0,0,6.396754483936666,40.29722761258207,ITGB1;EGR1;STMN1;FOS;CDK5R1
696,Reactome_2022,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,2 of 36,0.0019096220383147,0.0099027542844036,0,0,34.48096885813149,215.8801718825925,CDKN1A;CCND1
697,Reactome_2022,Glutathione Conjugation R-HSA-156590,2 of 36,0.0019096220383147,0.0099027542844036,0,0,34.48096885813149,215.8801718825925,GCLC;CHAC1
698,Reactome_2022,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,3 of 140,0.0020240566460441,0.0103483459509016,0,0,13.156602521566024,81.60582090172413,APP;JUN;FOS
699,Reactome_2022,Diseases Of Mitotic Cell Cycle R-HSA-9675126,2 of 38,0.002126086756898,0.0107190207326942,0,0,32.56209150326797,200.36992458923652,CDKN1A;CCND1
700,Reactome_2022,"Cell Cycle, Mitotic R-HSA-69278",5 of 523,0.0023146372130532,0.0115097713471003,0,0,6.054925893635571,36.74433180358032,TOP2A;CDKN1A;CCND1;CDK1;MNAT1
701,Reactome_2022,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,2 of 44,0.0028416743909962,0.0139395649179948,0,0,27.90196078431373,163.5992917401365,ITGB1;SMAD7
702,Reactome_2022,SUMOylation Of DNA Replication Proteins R-HSA-4615885,2 of 45,0.0029704902359377,0.0143687184927958,0,0,27.251709986320108,158.57847101200235,TOP2A;SUMO2
703,Reactome_2022,S Phase R-HSA-69242,3 of 161,0.0030083267367837,0.0143687184927958,0,0,11.395857307249711,66.16857830848699,CDKN1A;CCND1;MNAT1
704,Reactome_2022,Toll-like Receptor Cascades R-HSA-168898,3 of 162,0.0030613215537674,0.0144319444677607,0,0,11.323613493424814,65.55136326266191,APP;JUN;FOS
705,Reactome_2022,RNA Polymerase I Transcription Initiation R-HSA-73762,2 of 46,0.0031020092699298,0.0144362739100579,0,0,26.63101604278075,153.81289852825822,MTA1;MNAT1
706,Reactome_2022,Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,2 of 52,0.0039473547117495,0.0181378450679125,0,0,23.42823529411765,129.66847920672666,MNAT1;HMGN1
707,Reactome_2022,G2/M Transition R-HSA-69275,3 of 182,0.0042442120867831,0.0192581123437784,0,0,10.048247841543931,54.88553017754977,CDKN1A;CDK1;MNAT1
708,Reactome_2022,Mitotic G2-G2/M Phases R-HSA-453274,3 of 184,0.0043757060215216,0.0196096455038564,0,0,9.936212958312408,53.97040268809236,CDKN1A;CDK1;MNAT1
709,Reactome_2022,ESR-mediated Signaling R-HSA-8939211,3 of 188,0.0046460834151383,0.0205674180450636,0,0,9.71941031941032,52.21005470741969,JUN;CCND1;FOS
710,Reactome_2022,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,2 of 59,0.0050534131683621,0.0218379640489936,0,0,20.54385964912281,108.62958976497576,CDKN1A;CDK1
711,Reactome_2022,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,2 of 59,0.0050534131683621,0.0218379640489936,0,0,20.54385964912281,108.62958976497576,CDKN1A;CCND1
712,Reactome_2022,Metabolism Of Proteins R-HSA-392499,9 of 1890,0.0052697893527086,0.0225051004121558,0,0,3.204501151869573,16.81005962683649,TOP2A;ACHE;APP;MTA1;SUMO2;CDK1;PAX6;XPC;SMAD7
713,Reactome_2022,Pre-NOTCH Transcription And Translation R-HSA-1912408,2 of 62,0.005566189950907,0.0232244477261982,0,0,19.51372549019608,101.29661717464448,JUN;CCND1
714,Reactome_2022,MAP Kinase Activation R-HSA-450294,2 of 62,0.005566189950907,0.0232244477261982,0,0,19.51372549019608,101.29661717464448,JUN;FOS
715,Reactome_2022,Signaling By NOTCH R-HSA-157118,3 of 203,0.005749395786984,0.0237162576213093,0,0,8.983636363636364,46.3435301472559,JUN;CCND1;YBX1
716,Reactome_2022,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,2 of 64,0.0059207729878119,0.0238804510508415,0,0,18.88235294117647,96.85303138215218,MNAT1;HMGN1
717,Reactome_2022,Semaphorin Interactions R-HSA-373755,2 of 64,0.0059207729878119,0.0238804510508415,0,0,18.88235294117647,96.85303138215218,ITGB1;CDK5R1
718,Reactome_2022,Cell Cycle R-HSA-1640170,5 of 654,0.0059969158981638,0.0239217634179501,0,0,4.800188876186689,24.560214189508383,TOP2A;CDKN1A;CCND1;CDK1;MNAT1
719,Reactome_2022,Dual Incision In TC-NER R-HSA-6782135,2 of 65,0.0061018564807015,0.0240758032879854,0,0,18.58169934640523,94.75109916063928,MNAT1;HMGN1
720,Reactome_2022,Interleukin-17 Signaling R-HSA-448424,2 of 69,0.0068512571060586,0.0267420035430031,0,0,17.46883230904302,87.0528360021458,JUN;FOS
721,Reactome_2022,Extra-nuclear Estrogen Signaling R-HSA-9009391,2 of 73,0.0076403289160953,0.0295046744313042,0,0,16.48135874067937,80.33532794767753,CCND1;FOS
722,Reactome_2022,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,2 of 76,0.0082578203549345,0.0304256947686153,0,0,15.81081081081081,75.83804984876704,SUMO2;XPC
723,Reactome_2022,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,2 of 77,0.0084684960541181,0.0304256947686153,0,0,15.59921568627451,74.43013434591808,MNAT1;HMGN1
724,Reactome_2022,Pre-NOTCH Expression And Processing R-HSA-1912422,2 of 78,0.0086815795559781,0.0304256947686153,0,0,15.393188854489164,73.06456811678535,JUN;CCND1
725,Reactome_2022,RNA Polymerase I Promoter Clearance R-HSA-73854,2 of 78,0.0086815795559781,0.0304256947686153,0,0,15.393188854489164,73.06456811678535,MTA1;MNAT1
726,Reactome_2022,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,2 of 78,0.0086815795559781,0.0304256947686153,0,0,15.393188854489164,73.06456811678535,GCLC;ATF4
727,Reactome_2022,Chromatin Modifying Enzymes R-HSA-3247509,3 of 238,0.0088957487858737,0.0304256947686153,0,0,7.6321083172147,36.040202845182606,MTA1;CCND1;EZH2
728,Reactome_2022,RNA Polymerase I Transcription R-HSA-73864,2 of 79,0.0088970620111385,0.0304256947686153,0,0,15.192513368983958,71.73956722387139,MTA1;MNAT1
729,Reactome_2022,Activated NTRK2 Signals Thru CDK5 R-HSA-9032845,1 of 5,0.0089684554827598,0.0304256947686153,0,0,142.57142857142858,672.0876744444516,CDK5R1
730,Reactome_2022,TFAP2 (AP-2) Family Regulates Transcription Of Cell Cycle Factors R-HSA-8866911,1 of 5,0.0089684554827598,0.0304256947686153,0,0,142.57142857142858,672.0876744444516,CDKN1A
731,Reactome_2022,G2/M DNA Replication Checkpoint R-HSA-69478,1 of 5,0.0089684554827598,0.0304256947686153,0,0,142.57142857142858,672.0876744444516,CDK1
732,Reactome_2022,MET Interacts With TNS Proteins R-HSA-8875513,1 of 5,0.0089684554827598,0.0304256947686153,0,0,142.57142857142858,672.0876744444516,ITGB1
733,Reactome_2022,SUMO Is Proteolytically Processed R-HSA-3065679,1 of 5,0.0089684554827598,0.0304256947686153,0,0,142.57142857142858,672.0876744444516,SUMO2
734,Reactome_2022,Drug-mediated Inhibition Of CDK4/CDK6 Activity R-HSA-9754119,1 of 5,0.0089684554827598,0.0304256947686153,0,0,142.57142857142858,672.0876744444516,CCND1
735,Reactome_2022,Post-translational Protein Modification R-HSA-597592,7 of 1383,0.0105663251089611,0.0348504220698369,0,0,3.2607257417802726,14.836573454532015,TOP2A;APP;MTA1;SUMO2;CDK1;XPC;SMAD7
736,Reactome_2022,Fibronectin Matrix Formation R-HSA-1566977,1 of 6,0.010752747305294,0.0348504220698369,0,0,114.05142857142856,516.9488201244333,ITGB1
737,Reactome_2022,PTK6 Regulates Cell Cycle R-HSA-8849470,1 of 6,0.010752747305294,0.0348504220698369,0,0,114.05142857142856,516.9488201244333,CCND1
738,Reactome_2022,Phosphorylation Of Emi1 R-HSA-176417,1 of 6,0.010752747305294,0.0348504220698369,0,0,114.05142857142856,516.9488201244333,CDK1
739,Reactome_2022,"SUMO Is Transferred From E1 To E2 (UBE2I, UBC9) R-HSA-3065678",1 of 6,0.010752747305294,0.0348504220698369,0,0,114.05142857142856,516.9488201244333,SUMO2
740,Reactome_2022,Peptide Hormone Metabolism R-HSA-2980736,2 of 89,0.0111818979711597,0.0359206102967343,0,0,13.4394861392833,60.38978076507706,ACHE;PAX6
741,Reactome_2022,Signaling By Nuclear Receptors R-HSA-9006931,3 of 260,0.0113016712882996,0.0359806745008173,0,0,6.970993986558189,31.24960434576556,JUN;CCND1;FOS
742,Reactome_2022,MAPK6/MAPK4 Signaling R-HSA-5687128,2 of 90,0.0114231912022327,0.0359806745008173,0,0,13.286096256684491,59.416879599414536,JUN;CDK1
743,Reactome_2022,Developmental Biology R-HSA-1266738,6 of 1073,0.0114979565897928,0.0359806745008173,0,0,3.542080599812558,15.81746535053347,ITGB1;JUN;CDKN1A;PAX6;CDK5R1;EZH2
744,Reactome_2022,"Activation Of NIMA Kinases NEK9, NEK6, NEK7 R-HSA-2980767",1 of 7,0.0125339166174689,0.0382337120348003,0,0,95.03809523809524,416.20194419543344,CDK1
745,Reactome_2022,Terminal Pathway Of Complement R-HSA-166665,1 of 7,0.0125339166174689,0.0382337120348003,0,0,95.03809523809524,416.20194419543344,CLU
746,Reactome_2022,RUNX3 Regulates CDKN1A Transcription R-HSA-8941855,1 of 7,0.0125339166174689,0.0382337120348003,0,0,95.03809523809524,416.20194419543344,CDKN1A
747,Reactome_2022,Transcriptional Regulation By RUNX3 R-HSA-8878159,2 of 95,0.0126639038591974,0.0383083091740722,0,0,12.568627450980392,54.91232765349326,CDKN1A;CCND1
748,Reactome_2022,HCMV Early Events R-HSA-9609690,2 of 96,0.0129188360685873,0.0387565082057619,0,0,12.434292866082604,54.07759605240032,ITGB1;EZH2
749,Reactome_2022,Potential Therapeutics For SARS R-HSA-9679191,2 of 97,0.0131760117301551,0.0392040349020188,0,0,12.302786377708978,53.263159193779046,ITGB1;MTA1
750,Reactome_2022,KEAP1-NFE2L2 Pathway R-HSA-9755511,2 of 100,0.0139609152364795,0.0412017254540006,0,0,11.92436974789916,50.93486932982207,GCLC;ATF4
751,Reactome_2022,Formyl Peptide Receptors Bind Formyl Peptides And Many Other Ligands R-HSA-444473,1 of 8,0.0143119685548053,0.0412320998840821,0,0,81.45714285714286,345.92071940977723,APP
752,Reactome_2022,RUNX3 Regulates WNT Signaling R-HSA-8951430,1 of 8,0.0143119685548053,0.0412320998840821,0,0,81.45714285714286,345.92071940977723,CCND1
753,Reactome_2022,Noncanonical Activation Of NOTCH3 R-HSA-9017802,1 of 8,0.0143119685548053,0.0412320998840821,0,0,81.45714285714286,345.92071940977723,YBX1
754,Reactome_2022,Phase II - Conjugation Of Compounds R-HSA-156580,2 of 107,0.0158693141798747,0.0445767000575903,0,0,11.125490196078433,46.09699962057723,GCLC;CHAC1
755,Reactome_2022,ATF6 (ATF6-alpha) Activates Chaperone Genes R-HSA-381183,1 of 9,0.0160869082852461,0.0445767000575903,0,0,71.27142857142857,294.3331456349383,ATF4
756,Reactome_2022,Processing And Activation Of SUMO R-HSA-3215018,1 of 9,0.0160869082852461,0.0445767000575903,0,0,71.27142857142857,294.3331456349383,SUMO2
757,Reactome_2022,CHL1 Interactions R-HSA-447041,1 of 9,0.0160869082852461,0.0445767000575903,0,0,71.27142857142857,294.3331456349383,ITGB1
758,Reactome_2022,E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,1 of 9,0.0160869082852461,0.0445767000575903,0,0,71.27142857142857,294.3331456349383,CDK1
759,Reactome_2022,RUNX3 Regulates p14-ARF R-HSA-8951936,1 of 10,0.0178587410119325,0.0473191458929307,0,0,63.34920634920635,254.99716559529236,CCND1
760,Reactome_2022,Condensation Of Prometaphase Chromosomes R-HSA-2514853,1 of 10,0.0178587410119325,0.0473191458929307,0,0,63.34920634920635,254.99716559529236,CDK1
761,Reactome_2022,MAPK3 (ERK1) Activation R-HSA-110056,1 of 10,0.0178587410119325,0.0473191458929307,0,0,63.34920634920635,254.99716559529236,CDK1
762,Reactome_2022,MASTL Facilitates Mitotic Progression R-HSA-2465910,1 of 10,0.0178587410119325,0.0473191458929307,0,0,63.34920634920635,254.99716559529236,CDK1
763,Reactome_2022,STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,1 of 10,0.0178587410119325,0.0473191458929307,0,0,63.34920634920635,254.99716559529236,CDKN1A
764,Reactome_2022,Neurotransmitter Clearance R-HSA-112311,1 of 10,0.0178587410119325,0.0473191458929307,0,0,63.34920634920635,254.99716559529236,ACHE
991,GO_Biological_Process_2023,Regulation Of DNA-templated Transcription (GO:0006355),18 of 1922,7.541241176812415e-10,5.505106059073064e-07,0,0,9.485294117647058,199.24300553245808,KLF10;EGR1;JUN;ARID3A;PAX6;XPC;FOS;YBX1;SOD2;SMAD7;GCLC;MTA1;HSF2;MNAT1;RNF111;CDK5R1;ATF4;EZH2
992,GO_Biological_Process_2023,Positive Regulation Of DNA-templated Transcription (GO:0045893),14 of 1243,1.2423800091793816e-08,3.759550617951251e-06,0,0,9.700791478659664,176.58983066660713,KLF10;EGR1;APP;JUN;PAX6;XPC;FOS;YBX1;MTA1;HSF2;PTMA;RNF111;ATF4;HMGN1
993,GO_Biological_Process_2023,Regulation Of Transcription By RNA Polymerase II (GO:0006357),17 of 2028,1.5450208018977743e-08,3.759550617951251e-06,0,0,7.987673061320631,143.66343903452727,KLF10;EGR1;APP;JUN;ARID3A;PAX6;FOS;YBX1;SOD2;SMAD7;MTA1;CCND1;HSF2;MNAT1;PTMA;ATF4;EZH2
994,GO_Biological_Process_2023,Regulation Of Neuron Apoptotic Process (GO:0043523),5 of 105,1.1999957009433349e-06,0.00021899921542215857,0,0,32.038709677419355,436.7898991662785,EGR1;SOD2;CLU;CDK5R1;ATF4
995,GO_Biological_Process_2023,Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071900),5 of 112,1.6521581709212143e-06,0.0002412150929544973,0,0,29.93216762134459,398.4997627712192,CDKN1A;CCND1;MNAT1;CDK5R1;EZH2
996,GO_Biological_Process_2023,Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904029),4 of 53,2.4304843733959585e-06,0.0002957089320965083,0,0,50.80357142857143,656.7591048419897,CDKN1A;CCND1;MNAT1;CDK5R1
997,GO_Biological_Process_2023,Regulation Of Apoptotic Process (GO:0042981),9 of 705,3.1978443733605574e-06,0.0003142746934563971,0,0,9.227969348659004,116.76180630657146,ITGB1;TOP2A;EGR1;JUN;GCLC;CDK1;PTMA;CLU;ATF4
998,GO_Biological_Process_2023,Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0007178),5 of 130,3.4441062296591465e-06,0.0003142746934563971,0,0,25.598709677419357,322.0022300826621,ITGB1;JUN;FOS;RNF111;SMAD7
999,GO_Biological_Process_2023,Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),10 of 938,4.09402219500417e-06,0.00033207068915033826,0,0,7.889588859416445,97.87810250074531,KLF10;EGR1;APP;JUN;HSF2;PAX6;FOS;YBX1;PTMA;ATF4
1000,GO_Biological_Process_2023,DNA Damage Response (GO:0006974),7 of 384,4.7027695575308725e-06,0.0003433021776997537,0,0,12.540839659745725,153.8429817061913,TOP2A;BTG2;CDKN1A;CCND1;CDK1;XPC;MNAT1
1001,GO_Biological_Process_2023,Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),8 of 557,5.233082803628167e-06,0.0003472864042407783,0,0,10.10408534998699,122.87083101355654,EGR1;JUN;MTA1;PAX6;XPC;FOS;RNF111;ATF4
1002,GO_Biological_Process_2023,Positive Regulation Of Apoptotic Process (GO:0043065),6 of 270,7.93750234637821e-06,0.0004678218742491448,0,0,14.924242424242424,175.26898817676852,ITGB1;TOP2A;JUN;CLU;CDK5R1;ATF4
1003,GO_Biological_Process_2023,Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0007179),4 of 72,8.334015310359583e-06,0.0004678218742491448,0,0,36.5735294117647,427.7334679739925,ITGB1;JUN;FOS;SMAD7
1004,GO_Biological_Process_2023,Negative Regulation Of DNA-templated Transcription (GO:0045892),10 of 1025,8.97192635546305e-06,0.0004678218742491448,0,0,7.180371352785146,83.44604051717697,KLF10;JUN;GCLC;MTA1;CCND1;PAX6;SMAD7;CDK5R1;ATF4;EZH2
1005,GO_Biological_Process_2023,Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079),4 of 79,1.2062934915122831e-05,0.0005870628325359777,0,0,33.14833333333333,375.4172405485044,CDKN1A;CCND1;MNAT1;CDK5R1
1006,GO_Biological_Process_2023,Cellular Response To Transforming Growth Factor Beta Stimulus (GO:0071560),4 of 96,2.6096833856651637e-05,0.0011906680447097,0,0,27.0,284.94980709754475,ITGB1;JUN;FOS;SMAD7
1007,GO_Biological_Process_2023,Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010389),3 of 35,3.369086284061756e-05,0.0014467252866853,0,0,56.625,583.1403252539716,CDKN1A;CCND1;CDK1
1008,GO_Biological_Process_2023,Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904705),3 of 37,3.989789745274057e-05,0.0016180813966944,0,0,53.288770053475936,539.7719131881752,JUN;CDKN1A;SOD2
1009,GO_Biological_Process_2023,Locomotor Rhythm (GO:0045475),2 of 6,4.70362917222177e-05,0.0018071838398536,0,0,293.52941176470586,2924.900561099222,EGR1;MTA1
1010,GO_Biological_Process_2023,Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),8 of 763,5.064753265870456e-05,0.0018100939495907,0,0,7.269252601702933,71.89741547280646,KLF10;JUN;MTA1;CCND1;PAX6;SMAD7;ATF4;EZH2
1011,GO_Biological_Process_2023,Regulation Of Cell Population Proliferation (GO:0042127),8 of 766,5.207119581014461e-05,0.0018100939495907,0,0,7.2393516773464,71.40099170887414,KLF10;APP;JUN;BTG2;CDKN1A;SOD2;CLU;EZH2
1012,GO_Biological_Process_2023,Cellular Response To Oxidative Stress (GO:0034599),4 of 117,5.669746838313012e-05,0.0018813250872584,0,0,21.95907079646018,214.71098515759087,JUN;FOS;SOD2;ATF4
1013,GO_Biological_Process_2023,Positive Regulation Of miRNA Transcription (GO:1902895),3 of 43,6.290123291013695e-05,0.0019964304358434,0,0,45.28181818181818,438.0538092327387,EGR1;JUN;FOS
1014,GO_Biological_Process_2023,Nonribosomal Peptide Biosynthetic Process (GO:0019184),2 of 7,6.577640515487366e-05,0.0020006989901274,0,0,234.81176470588235,2261.0610369428987,GCLC;CHAC1
1015,GO_Biological_Process_2023,Positive Regulation Of Programmed Cell Death (GO:0043068),5 of 245,7.320582209134991e-05,0.0021376100050674,0,0,13.255376344086022,126.2208165600268,ITGB1;TOP2A;JUN;CLU;ATF4
1016,GO_Biological_Process_2023,Plasma Membrane Bounded Cell Projection Organization (GO:0120036),4 of 132,9.064939448181845e-05,0.0025201835630463,0,0,19.37109375,180.3160450753649,APP;BTG2;STMN1;CDK5R1
1017,GO_Biological_Process_2023,Positive Regulation Of miRNA Metabolic Process (GO:2000630),3 of 49,9.321226877020766e-05,0.0025201835630463,0,0,39.36363636363637,365.3193920089891,EGR1;JUN;FOS
1018,GO_Biological_Process_2023,SMAD Protein Signal Transduction (GO:0060395),3 of 51,0.00010509960440120591,0.0027400968290314,0,0,37.71969696969697,345.53513316386227,JUN;FOS;SMAD7
1019,GO_Biological_Process_2023,Regulation Of Tau-Protein Kinase Activity (GO:1902947),2 of 9,0.00011250476197410829,0.0028320164221068,0,0,167.7058823529412,1524.868252317394,EGR1;CLU
1020,GO_Biological_Process_2023,Positive Regulation Of Protein Kinase Activity (GO:0045860),4 of 145,0.00013035358440931176,0.0030856553921804,0,0,17.57358156028369,157.20025477533522,EGR1;CDKN1A;CLU;EZH2
1021,GO_Biological_Process_2023,Regulation Of Gene Expression (GO:0010468),9 of 1127,0.00013103468103780068,0.0030856553921804,0,0,5.618962432915922,50.2337968332008,EGR1;ACTA1;APP;MTA1;PAX6;YBX1;CLU;ATF4;EZH2
1022,GO_Biological_Process_2023,Mitotic DNA Damage Checkpoint Signaling (GO:0044773),3 of 56,0.00013903588612146947,0.003171756152146,0,0,34.15265866209263,303.30219623884494,CDKN1A;CCND1;CDK1
1023,GO_Biological_Process_2023,Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),6 of 456,0.0001481600612394717,0.0031892796153829,0,0,8.672888888888888,76.47074659156806,KLF10;JUN;GCLC;MTA1;CDK5R1;EZH2
1024,GO_Biological_Process_2023,Neuron Development (GO:0048666),4 of 150,0.00014854179030550704,0.0031892796153829,0,0,16.96746575342466,149.56217398429115,APP;BTG2;STMN1;CDK5R1
1025,GO_Biological_Process_2023,DNA Metabolic Process (GO:0006259),5 of 288,0.0001563829314268606,0.0032380536123749,0,0,11.216801550210874,98.2951075359962,TOP2A;BTG2;CDK1;XPC;MNAT1
1026,GO_Biological_Process_2023,Regulation Of miRNA Transcription (GO:1902893),3 of 59,0.0001624531321877173,0.0032380536123749,0,0,32.31818181818182,281.9800473516767,EGR1;JUN;FOS
1027,GO_Biological_Process_2023,DNA Repair (GO:0006281),5 of 291,0.00016412052555872785,0.0032380536123749,0,0,11.097450936160614,96.71328045740532,BTG2;MTA1;CDK1;XPC;MNAT1
1028,GO_Biological_Process_2023,Negative Regulation Of Apoptotic Process (GO:0043066),6 of 482,0.00020015737032543784,0.003845128429936,0,0,8.188235294117646,69.73434150399258,ITGB1;GCLC;CDK1;SOD2;PTMA;CLU
1029,GO_Biological_Process_2023,Cellular Response To Reactive Oxygen Species (GO:0034614),3 of 73,0.00030547785732446545,0.0057179188678682,0,0,25.83636363636364,209.11005209887384,JUN;FOS;CLU
1030,GO_Biological_Process_2023,Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806),3 of 74,0.0003179926173270372,0.0058029413829885,0,0,25.471190781049938,205.1317864433363,CDKN1A;MNAT1;EZH2
1031,GO_Biological_Process_2023,Regulation Of Amyloid Fibril Formation (GO:1905906),2 of 15,0.0003259186256199044,0.0058029413829885,0,0,90.27601809954751,724.8137654755144,APP;CLU
1032,GO_Biological_Process_2023,Negative Regulation Of Cellular Process (GO:0048523),6 of 537,0.0003575750677231894,0.0062149952247125,0,0,7.31939736346516,58.0879469207067,KLF10;APP;BTG2;CDKN1A;SOD2;CLU
1033,GO_Biological_Process_2023,Neuron Projection Development (GO:0031175),4 of 192,0.00038126871784231015,0.006307861942224,0,0,13.148936170212766,103.5085062041621,APP;BTG2;STMN1;CDK5R1
1034,GO_Biological_Process_2023,Cellular Response To UV (GO:0034644),3 of 79,0.0003855337141487664,0.006307861942224,0,0,23.789473684210527,187.00624340747535,CDKN1A;XPC;ATF4
1035,GO_Biological_Process_2023,Regulation Of Cell Differentiation (GO:0045595),4 of 193,0.0003888408046576447,0.006307861942224,0,0,13.078703703703704,102.69843531152922,MTA1;SMAD7;CDK5R1;ATF4
1036,GO_Biological_Process_2023,Negative Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904706),2 of 17,0.0004211879595115378,0.0066840697922483,0,0,78.23137254901961,608.0479736697338,CDKN1A;SOD2
1037,GO_Biological_Process_2023,Positive Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032436),3 of 83,0.0004457417281273988,0.0067789887819375,0,0,22.595454545454544,174.34134971852123,SUMO2;CLU;SMAD7
1038,GO_Biological_Process_2023,Positive Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000060),3 of 83,0.0004457417281273988,0.0067789887819375,0,0,22.595454545454544,174.34134971852123,SUMO2;CLU;SMAD7
1039,GO_Biological_Process_2023,Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),5 of 364,0.0004604645892429896,0.006859982656069,0,0,8.808069008895679,67.67481290474053,EGR1;APP;PAX6;CLU;ATF4
1040,GO_Biological_Process_2023,Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901990),3 of 86,0.0004946471577325671,0.0072218485028954,0,0,21.775465498357065,165.74756736798554,CDKN1A;XPC;MNAT1
1041,GO_Biological_Process_2023,Release Of Cytochrome C From Mitochondria (GO:0001836),2 of 19,0.0005283848977383165,0.007427577842061,0,0,69.02076124567473,520.8089619438341,SOD2;CLU
1042,GO_Biological_Process_2023,Negative Regulation Of Neuron Death (GO:1901215),3 of 88,0.0005290877366947582,0.007427577842061,0,0,21.26096256684492,160.40027658743577,SOD2;CLU;ATF4
1043,GO_Biological_Process_2023,Negative Regulation Of Cell Population Proliferation (GO:0008285),5 of 379,0.000553261271322067,0.007620391095568,0,0,8.448335345868554,63.359813369707176,KLF10;APP;BTG2;CDKN1A;SOD2
1044,GO_Biological_Process_2023,Positive Regulation Of Proteasomal Protein Catabolic Process (GO:1901800),3 of 90,0.0005650294233417003,0.0076383607229526,0,0,20.770114942528732,155.33206186084237,SUMO2;CLU;SMAD7
1045,GO_Biological_Process_2023,Microglial Cell Activation (GO:0001774),2 of 20,0.000586430503116779,0.0077835321322772,0,0,65.18300653594771,485.05650058138406,APP;CLU
1046,GO_Biological_Process_2023,Negative Regulation Of Amide Metabolic Process (GO:0034249),3 of 93,0.0006218147950602794,0.0081058000070357,0,0,20.074747474747475,148.20921609335653,BTG2;YBX1;CLU
1047,GO_Biological_Process_2023,Positive Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010971),2 of 21,0.0006474272021420127,0.0081486527166149,0,0,61.749226006191954,453.3939512870567,CCND1;CDK1
1048,GO_Biological_Process_2023,Response To Cadmium Ion (GO:0046686),2 of 21,0.0006474272021420127,0.0081486527166149,0,0,61.749226006191954,453.3939512870567,JUN;FOS
1049,GO_Biological_Process_2023,Positive Regulation Of Supramolecular Fiber Organization (GO:1902905),3 of 96,0.000682126294766358,0.0084262791300027,0,0,19.424242424242426,141.60847168791395,APP;CLU;CDK5R1
1050,GO_Biological_Process_2023,Positive Regulation Of Protein Modification Process (GO:0031401),4 of 225,0.0006925708873974891,0.0084262791300027,0,0,11.16685520361991,81.23998785264891,EGR1;APP;CDKN1A;CCND1
1051,GO_Biological_Process_2023,Cellular Response To Cadmium Ion (GO:0071276),2 of 22,0.0007113647786947809,0.0085130539089703,0,0,58.65882352941176,425.1782293491763,JUN;FOS
1052,GO_Biological_Process_2023,Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),3 of 98,0.0007243359990151877,0.0085284722464691,0,0,19.013397129186604,137.47171320050725,BTG2;CDKN1A;YBX1
1053,GO_Biological_Process_2023,Axon Development (GO:0061564),3 of 99,0.0007460510234598187,0.0086447182083439,0,0,18.814393939393938,135.47711808178047,APP;CCK;CDK5R1
1054,GO_Biological_Process_2023,Negative Regulation Of Oxidative Stress-Induced Cell Death (GO:1903202),2 of 23,0.0007782330418291474,0.0088767206333637,0,0,55.86274509803921,399.8925970911249,SOD2;ATF4
1055,GO_Biological_Process_2023,Positive Regulation Of Cell Cycle G2/M Phase Transition (GO:1902751),2 of 24,0.0008480218264323183,0.0095239374353168,0,0,53.32085561497326,377.1173065055224,CCND1;CDK1
1056,GO_Biological_Process_2023,Intrinsic Apoptotic Signaling Pathway (GO:0097193),3 of 105,0.0008850807175312614,0.0097895291484518,0,0,17.702317290552585,124.44431144492688,CDKN1A;CHAC1;ATF4
1057,GO_Biological_Process_2023,Regulation Of Cell Cycle Phase Transition (GO:1901987),2 of 25,0.0009207209919278048,0.0100317361807059,0,0,51.0,356.5080289062332,CDKN1A;XPC
1058,GO_Biological_Process_2023,Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032434),3 of 109,0.000986315481551003,0.0105407812952131,0,0,17.030874785591767,117.8797838773428,SUMO2;CLU;SMAD7
1059,GO_Biological_Process_2023,Mitotic G1 DNA Damage Checkpoint Signaling (GO:0031571),2 of 26,0.0009963204237941185,0.0105407812952131,0,0,48.872549019607845,337.7797704194284,CDKN1A;CCND1
1060,GO_Biological_Process_2023,Mitotic Cell Cycle Phase Transition (GO:0044772),3 of 111,0.0010395694922328,0.0108412247047139,0,0,16.713804713804713,114.8062655113876,CDKN1A;CCND1;CDK1
1061,GO_Biological_Process_2023,Response To Endoplasmic Reticulum Stress (GO:0034976),3 of 114,0.0011228123475389,0.0115444086437106,0,0,16.25962325962326,110.4340395393208,JUN;CHAC1;ATF4
1062,GO_Biological_Process_2023,Integrated Stress Response Signaling (GO:0140467),2 of 29,0.0012404195444664,0.0125764759369513,0,0,43.43572984749456,290.6851787186678,JUN;FOS
1063,GO_Biological_Process_2023,Intrinsic Apoptotic Signaling Pathway In Response To Endoplasmic Reticulum Stress (GO:0070059),2 of 30,0.00132751939454,0.0130957994326247,0,0,41.88235294117647,277.4472679372888,CHAC1;ATF4
1064,GO_Biological_Process_2023,Mitotic G2 DNA Damage Checkpoint Signaling (GO:0007095),2 of 30,0.00132751939454,0.0130957994326247,0,0,41.88235294117647,277.4472679372888,CDKN1A;CDK1
1065,GO_Biological_Process_2023,Regulation Of Mitotic Cell Cycle (GO:0007346),3 of 125,0.0014637189770865,0.0142468647103087,0,0,14.785394932935915,96.50094360946784,APP;BTG2;XPC
1066,GO_Biological_Process_2023,Cellular Response To Starvation (GO:0009267),3 of 126,0.0014975739842502,0.0143845922171401,0,0,14.664449371766445,95.37624166842092,KLF10;CDKN1A;ATF4
1067,GO_Biological_Process_2023,Positive Regulation Of Gene Expression (GO:0010628),5 of 480,0.0015907408928547,0.0150810500231683,0,0,6.617657045840407,42.64123979923782,EGR1;APP;PAX6;CLU;ATF4
1068,GO_Biological_Process_2023,Positive Regulation Of Neuron Death (GO:1901216),2 of 34,0.0017043199561329,0.0157487793414819,0,0,36.63970588235294,233.5630697638135,CLU;CDK5R1
1069,GO_Biological_Process_2023,Apoptotic Mitochondrial Changes (GO:0008637),2 of 34,0.0017043199561329,0.0157487793414819,0,0,36.63970588235294,233.5630697638135,SOD2;CLU
1070,GO_Biological_Process_2023,Macrophage Activation (GO:0042116),2 of 35,0.0018055707503116,0.0164437760096827,0,0,35.52762923351159,224.42371839876355,APP;CLU
1071,GO_Biological_Process_2023,Cellular Response To Metal Ion (GO:0071248),3 of 135,0.0018245833654579,0.0164437760096827,0,0,13.658402203856747,86.13539697766636,JUN;FOS;CLU
1072,GO_Biological_Process_2023,Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),3 of 137,0.0019028193851738,0.0169397335509376,0,0,13.453188602442332,84.27640498778267,BTG2;CDKN1A;YBX1
1073,GO_Biological_Process_2023,Negative Regulation Of Smooth Muscle Cell Proliferation (GO:0048662),2 of 37,0.0020164639791465,0.0177351651177947,0,0,33.49411764705882,207.87822023706013,CDKN1A;SOD2
1074,GO_Biological_Process_2023,Negative Regulation Of Protein Metabolic Process (GO:0051248),3 of 147,0.002325402411701,0.0202088542921642,0,0,12.512626262626265,75.87484109907041,BTG2;YBX1;CLU
1075,GO_Biological_Process_2023,Regulation Of Microtubule Polymerization (GO:0031113),2 of 40,0.0023536356819974,0.0202135770336248,0,0,30.845201238390093,186.6688052523798,STMN1;CDK5R1
1076,GO_Biological_Process_2023,Regulation Of Chemokine Production (GO:0032642),2 of 41,0.0024715423197367,0.020979370853579,0,0,30.052790346907997,180.4042829225449,EGR1;APP
1077,GO_Biological_Process_2023,Cellular Response To Amino Acid Starvation (GO:0034198),2 of 42,0.0025921907757449,0.0217505662792392,0,0,29.3,174.48888071240097,CDKN1A;ATF4
1078,GO_Biological_Process_2023,Negative Regulation Of Gene Expression (GO:0010629),4 of 336,0.003016159236197,0.0250204118457252,0,0,7.391566265060241,42.89895817826715,APP;BTG2;YBX1;EZH2
1079,GO_Biological_Process_2023,Mitotic G2/M Transition Checkpoint (GO:0044818),2 of 46,0.0031020092699298,0.0254434468207726,0,0,26.63101604278075,153.81289852825822,CDKN1A;CDK1
1080,GO_Biological_Process_2023,Cell Cycle G1/S Phase Transition (GO:0044843),2 of 52,0.0039473547117495,0.0320174326619686,0,0,23.42823529411765,129.66847920672666,CDKN1A;CCND1
1081,GO_Biological_Process_2023,Protein Homotetramerization (GO:0051289),2 of 53,0.0040975287076647,0.0325129995282096,0,0,22.967704728950405,126.26199945397896,SOD2;CLU
1082,GO_Biological_Process_2023,Positive Regulation Of Chemokine Production (GO:0032722),2 of 53,0.0040975287076647,0.0325129995282096,0,0,22.967704728950405,126.26199945397896,EGR1;APP
1083,GO_Biological_Process_2023,Neuron Migration (GO:0001764),2 of 55,0.0044057485573151,0.034582757492904,0,0,22.098779134295228,119.88245371315708,CCK;CDK5R1
1084,GO_Biological_Process_2023,Nucleotide-Excision Repair (GO:0006289),2 of 56,0.0045637756240171,0.035069012689816,0,0,21.688453159041394,116.89219581217986,XPC;RNF111
1085,GO_Biological_Process_2023,Positive Regulation Of Cellular Metabolic Process (GO:0031325),2 of 56,0.0045637756240171,0.035069012689816,0,0,21.688453159041394,116.89219581217986,CDKN1A;CDK1
1086,GO_Biological_Process_2023,Axonogenesis (GO:0007409),3 of 188,0.0046460834151383,0.0353295926359477,0,0,9.71941031941032,52.21005470741969,APP;CCK;CDK5R1
1087,GO_Biological_Process_2023,Positive Regulation Of Interleukin-1 Beta Production (GO:0032731),2 of 57,0.004724401633422,0.035554775179362,0,0,21.29304812834225,114.024578590942,EGR1;APP
1088,GO_Biological_Process_2023,Regulation Of Neuron Death (GO:1901214),2 of 58,0.0048876172516927,0.03604000599733,0,0,20.91176470588235,111.27255319681896,EGR1;CLU
1089,GO_Biological_Process_2023,Peptidyl-Threonine Phosphorylation (GO:0018107),2 of 58,0.0048876172516927,0.03604000599733,0,0,20.91176470588235,111.27255319681896,CDK1;CDK5R1
1090,GO_Biological_Process_2023,Microtubule Cytoskeleton Organization Involved In Mitosis (GO:1902850),2 of 59,0.0050534131683621,0.0368899161290438,0,0,20.54385964912281,108.62958976497576,STMN1;CDK1
1091,GO_Biological_Process_2023,protein-DNA Complex Organization (GO:0071824),2 of 60,0.0052217800953762,0.0377415789071749,0,0,20.188640973630832,106.0896310598831,EZH2;HMGN1
1092,GO_Biological_Process_2023,Negative Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001243),2 of 61,0.0053927087697511,0.0385638616368632,0,0,19.845463609172484,103.6470509502107,SOD2;CLU
1093,GO_Biological_Process_2023,DNA-templated Transcription (GO:0006351),3 of 199,0.0054412023953382,0.0385638616368632,0,0,9.168831168831169,47.80404131262037,MNAT1;PTMA;ATF4
1094,GO_Biological_Process_2023,Regulation Of Translation (GO:0006417),3 of 202,0.0056713837661942,0.0395454389413297,0,0,9.029237094563728,46.70212293642212,APP;BTG2;YBX1
1095,GO_Biological_Process_2023,G1/S Transition Of Mitotic Cell Cycle (GO:0000082),2 of 63,0.0057422144216177,0.0395454389413297,0,0,19.19286403085825,99.03345786086956,CDKN1A;CCND1
1096,GO_Biological_Process_2023,Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992),2 of 63,0.0057422144216177,0.0395454389413297,0,0,19.19286403085825,99.03345786086956,CCND1;CDK1
1097,GO_Biological_Process_2023,Cellular Response To Oxygen-Containing Compound (GO:1901701),4 of 406,0.0058997408841375,0.04002003963984,0,0,6.08271144278607,31.22162625017949,EGR1;JUN;FOS;CLU
1098,GO_Biological_Process_2023,Positive Regulation Of Interleukin-1 Production (GO:0032732),2 of 64,0.0059207729878119,0.04002003963984,0,0,18.88235294117647,96.85303138215218,EGR1;APP
1099,GO_Biological_Process_2023,Positive Regulation Of Cell Cycle (GO:0045787),2 of 65,0.0061018564807015,0.0408656443202947,0,0,18.58169934640523,94.75109916063928,APP;CCND1
1100,GO_Biological_Process_2023,Peptidyl-Threonine Modification (GO:0018210),2 of 66,0.0062854557508785,0.0413367810643365,0,0,18.290441176470587,92.72370111910996,CDK1;CDK5R1
1101,GO_Biological_Process_2023,Response To Reactive Oxygen Species (GO:0000302),2 of 66,0.0062854557508785,0.0413367810643365,0,0,18.290441176470587,92.72370111910996,JUN;FOS
1102,GO_Biological_Process_2023,Negative Regulation Of Supramolecular Fiber Organization (GO:1902904),2 of 71,0.0072408702404945,0.0471949578175093,0,0,16.96078431372549,83.58298052804865,STMN1;CLU
1103,GO_Biological_Process_2023,Response To Ionizing Radiation (GO:0010212),2 of 72,0.0074393733819704,0.0480596687507822,0,0,16.71764705882353,81.93266424635078,CDKN1A;MTA1
1104,GO_Biological_Process_2023,Protein Tetramerization (GO:0051262),2 of 73,0.0076403289160953,0.0489249132346453,0,0,16.48135874067937,80.33532794767753,SOD2;CLU
1105,GO_Biological_Process_2023,Negative Regulation Of Neuron Apoptotic Process (GO:0043524),2 of 74,0.0078437278787706,0.0497906204478485,0,0,16.251633986928105,78.78858890769375,SOD2;CLU
